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Wnt/b-catenin signalling is known to play many roles in metazoan devel-
opment and tissue homeostasis. Misregulation of the pathway has also been
linked to many human diseases. In this review, specific aspects of the path-
way’s involvement in these processes are discussed, with an emphasis on how
Wnt/b-catenin signalling regulates gene expression in a cell and temporally
specific manner. The T-cell factor (TCF) family of transcription factors,
which mediate a large portion of Wnt/b-catenin signalling, will be discussed
in detail. Invertebrates contain a single TCF gene that contains two DNA-
binding domains, the high mobility group (HMG) domain and the C-clamp,
which increases the specificity of DNA binding. In vertebrates, the situation
is more complex, with four TCF genes producing many isoforms that contain
the HMG domain, but only some of which possess a C-clamp. Vertebrate
TCFs have been reported to act in concert with many other transcription
factors, which may explain how they obtain sufficient specificity for specific
DNA sequences, as well as how they achieve a wide diversity of transcrip-
tional outputs in different cells.
Keywords C-clamp, high mobility group domain, lymphoid enhancer-
binding factor 1, T-cell factor, Wnt, b-catenin.
Wnts are a family of secreted proteins that can exert
profound influences on cell behaviour through activa-
tion of several signalling pathways. In this review, we
focus on the best-understood Wnt signalling pathway,
sometimes called ‘canonical’ Wnt signalling but here-
after referred to as Wnt/b-catenin signalling. This
particular Wnt pathway acts by increasing levels of
nuclear b-catenin, which then serves as a co-regulator
for transcription factors that can recruit b-catenin to
specific regulatory elements (Cadigan 2008, Cadigan &
Peifer 2009, MacDonald et al. 2009). This pathway is
known to play many pivotal roles in animal develop-
ment (Logan & Nusse 2004, Grigoryan et al. 2008,
Petersen & Reddien 2009, Niehrs 2010) and adult
tissue maintenance (Polakis 2007, Nusse et al. 2008,
Haegebarth & Clevers 2009, Wend et al. 2010). In
addition, aberrant Wnt signalling has been linked to
several human diseases, most notably (but not restricted
to) several cancers (Clevers 2006, Polakis 2007). This
review covers a few examples of Wnt/b-catenin signal-
ling in normal and pathological contexts, where some
information is known about the transcriptional targets.
The ability of this pathway to activate diverse tran-
scriptional programs in different contexts is remarkable,
and we discuss some of the mechanisms that contribute
to this diversity of transcriptional output.
Most of our attention will focus on the T-cell factor/
lymphoid enhancer-binding factor 1 (TCF/LEF1) (TCF)
family of high mobility group (HMG) domain proteins,
which act with b-catenin to regulate numerous Wnt
targets. But we also discuss other DNA-binding proteins
that utilize b-catenin to regulate gene expression. It is
unlikely that TCFs possess enough DNA-binding spec-
ificity to account for their ability to find specific Wnt
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response elements (WREs) among the huge excess of
genomic DNA sequences. How TCFs interact with other
transcription factors to increase DNA-binding specificity
will be discussed. These interactions likely contribute to
the differences in target gene expression that the Wnt/b-
catenin pathway achieves in different cellular contexts.
b-catenin is most commonly thought of as a tran-
scriptional co-activator, and this is reflected in our
current knowledge of direct targets of Wnt/b-catenin
regulation, which are predominately activated in
response to Wnt signalling. But we also discuss reports
that link b-catenin to direct transcriptional repression, a
less common form of Wnt regulation, but one that might
be currently underappreciated among Wnt researchers.
Overview of Wnt/b-signalling
The overall stability and nuclear localization of b-cate-
nin is thought to play a central role in determining the
level of Wnt/b catenin signalling. In the absence of Wnt
stimulation, b-catenin is constitutively inhibited by a
complex (termed the b-catenin destruction complex)
containing glycogen synthase kinase 3 (GSK3) and
casein kinase I (CKI), as well as the scaffolding proteins
Axin and adenomatous polyposis coli (APC) protein
(Cadigan & Peifer 2009, Kennell & Cadigan 2009).
Phosphorylation of specific residues in the N-terminus
of b-catenin by CKI and GSK3 is followed by ubiqui-
tination and proteosomal degradation (Cadigan &
Peifer 2009, MacDonald et al. 2009), (Fig. 1). In
addition, Axin and APC are thought to sequester
b-catenin in the cytosol, and/or to promote b-catenin
efflux from the nucleus (Brocardo & Henderson 2008).
Without Wnt signalling, the b-catenin destruction
complex keeps the level of b-catenin low, restricting
b-catenin to its essential role in supporting cadherin-
mediated cell adhesion (Stepniak et al. 2009).
When Wnt protein is recognized at the cell surface by
members of the Frizzled (Fz) family of proteins and low
density lipoprotein receptor related protein 5 or 6 (LRP
5/6), a large complex termed the ‘Wnt signalosome’ is
formed (Cadigan & Peifer 2009, MacDonald et al.
2009). The signalosome interacts with the b-catenin
destruction complex, inhibiting its activity. This results
in the accumulation of b-catenin, some of which enters
the nucleus (Fig. 1).
Once in the nucleus, b-catenin can bind to several
DNA-binding proteins, the best understood of which
are the TCFs. Some TCFs are thought to act as a
transcriptional switch, repressing Wnt target gene
expression in the absence of signalling and activating
transcription upon forming a complex with b-catenin
(Fig. 1). There is also a wealth of information on other
transcriptional co-factors that contribute to TCF repres-
sion in the absence of Wnt signalling or are required for
b-catenin-dependent activation of Wnt targets. These
factors, several of which alter the state of Wnt target
gene chromatin, will not be discussed in detail here, but
can be explored in several recent reviews (Arce et al.
2006, Willert & Jones 2006, Cadigan & Peifer 2009,
Mosimann et al. 2009).
The TCF family: a historical perspective
The TCF family of transcription factors was first
discovered by researchers interested in lymphocyte gene
(a) (b)
Figure 1 Basic outline of the Wnt/b-catenin signalling pathway. (a) In the absence of the Wnt ligand, b-catenin is phosphory-
lated by a ‘destruction’ complex containing APC, Axin and the CKI and GSK3 kinases. These results in ubiquitylation and
proteosomal degradation of b-catenin. In the nucleus, TCF can recruit co-repressors to Wnt targets, keeping their rate of
transcription very low. (b) When Wnt ligand binds to the Fz and LRP5/6 co-receptors, the destruction complex moves to the plasma
membrane through multiple protein–protein interactions with the receptor complex and Dvl. b-catenin is no longer phosphorylated/
degraded and newly synthesized/b-catenin accumulates in the cytosol and the nucleus. Nuclear b-catenin binds to TCFs,
displacing co-repressors and recruiting co-activators to increase expression of Wnt targets. See the text for more details. APC,
adenomatous polyposis coli; CKI, casein kinase I; GSK3, glycogen synthase kinase 3; TCF, T-cell factor 1; Fz, Frizzled; LRP,
lipoprotein receptor related protein; Dvl, Dishevelled.
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regulation. A protein originally called TCF1 a or
lymphoid enhancer-binding factor 1 (LEF1) was highly
expressed in pre-B and pre-T cells and bound a specific
DNA sequence in an enhancer controlling the T-cell
receptor a (TCRa) gene (Waterman & Jones 1990,
Waterman et al. 1991) (Travis et al. 1991). Another
protein enriched in immature T cells called TCF1 bound
to a similar sequence in a CD3a enhancer (van de
Wetering et al. 1991). Both LEF1 and TCF1 were found
to contain a single HMG domain, which was sufficient
for DNA-specific binding (Giese et al. 1991, Oosterwe-
gel et al. 1991, Waterman et al. 1991). HMG domains
are found in animals, plants and fungi, and TCF1 and
LEF1 belong to a subgroup within this family, most
closely related to the HMG domains of SOX proteins
(e.g. SRY) and fungal mating type proteins (e.g. STE11)
(Laudet et al. 1993).
In addition to sequence specific DNA binding, the
HMG domain of LEF1 has been shown to bend DNA
up to 130, (Giese et al. 1992) which was confirmed by
solving the crystal structure of a LEF1–DNA-binding
site complex (Love et al. 1995). This bending has been
proposed to play an architectural role in coordinating
the binding of several other factors to the TCRa
enhancer (Carlsson et al. 1993, Giese & Grosschedl
1993, Giese et al. 1995). This protein–enhancer com-
plex is sometimes referred to as the ‘T cell enhanceo-
some’ (Balmelle et al. 2004). The high degree of
conservation between the HMG domains of the TCF
family (Fig. 2) suggests that all members have the ability
to bend DNA, though this remains to be tested directly.
Although interest in LEF1 and TCF1 was initially
focused on lymphocytes, the finding that mice lacking a
functional LEF1 gene displayed defects to several organ
systems indicated a much broader role in developmental
biology (van Genderen et al. 1994). This connection
was further solidified by the findings that LEF1 and
TCF3 (another member of the family) could bind to
(a)
(b)
Figure 2 (a) Cartoon depicting the Drosophila TCF/Pan (the PanA isoform; 751 aa) showing the location of the b-catenin binding
domain (green), the HMG domain (red), the basic tail (aqua) and the C-clamp (blue). (b) Alignment of the HMG domains, basic tails
and C-clamps among metazoan TCFs. Non-conserved residues are not coloured in the alignment. The positions of the three a-helices
of the HMG domain, based on the structure of LEF1 (Love et al. 1995) are indicated at the top of the figure. The six invertebrate
TCFs possess all three domains, while only the E box isoforms of vertebrate TCF1 and TCF4 possess C-clamps. The degree of
conservation in the HMG domain is quite high, e.g. the TCF of Suberities domuncula and human TCF4E are 79.5% identical, 85.9%
conserved. The C-clamp is less conserved (55.2% identity; 58.6% for the S. domuncula-human TCF4E comparison). The number of
non-conserved residues between the basic tail and C-clamps are highly variable. The GenBank accession number of each protein
sequence is in parentheses: S. domuncula (CAH04889.1); Amphimedon queenslandica (ADO16566.1); Mnemiopsis leidyi
(ADO34164.1); Hydra magnipapillata (XP_002159974.1); Caenorhabditis elegans (NP_491053.3); Drosophila melanogaster
(isoform A; NP_726522); human TCF1E (EAW62279.1); TCF4E (CAB97213.1); LEF1 (NP_001124185) and TCF3
(NP_112573.1). TCF, T-cell factor 1; HMG, high mobility group; LEF1, lymphoid enhancer-binding factor 1.
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b-catenin (Behrens et al. 1996, Huber et al. 1996,
Molenaar 1996). It was known that mutants in the fly
homolog of b-catenin, armadillo (arm) caused defects
very similar to wingless (wg) mutants, a Wnt gene
important in many aspects of fly development
(Riggleman et al. 1989, Peifer et al. 1991, Noordermeer
et al. 1994, Siegfried et al. 1994). In addition, mis-
expression of b-catenin in ventral blastomeres of
Xenopus embryos induced a secondary body axis
(Heasman et al. 1994), reminiscent of misexpression
of several Wnt genes (McMahon & Moon 1989, Smith
& Harland 1991, Sokol et al. 1991).
The N-terminus of TCFs are required for binding to
b-catenin, and deletion of this portion of a TCF gene
produces a protein that can dominantly inhibit Wnt
signalling in several organisms (Behrens et al. 1996,
Molenaar 1996, van de Wetering et al. 1997, Kratoch-
wil et al. 2002). In addition, placing multiple copies of
high affinity TCF binding sites upstream of a minimal
promoter-reporter gene cassette results in reporter gene
expression that is highly activated by Wnt/b-catenin
signalling (Molenaar 1996, Korinek et al. 1997, van de
Wetering et al. 1997). These now classic observations
contribute to the current working model of Wnt target
gene activation depicted in (Fig. 1).
Wnt/b-catenin signalling in development
Stimulation of theWnt/b-catenin pathway can result in a
diverse array of cellular outcomes, depending on the
context. For example, inDrosophila, the flyWnt protein
Wg acts through Arm to promote cell stem identity (Lin
et al. 2008, Takashima et al. 2008, Sinenko et al. 2009).
While Wg/Arm signalling stimulates proliferation in
several tissues (Baker 2007, Herranz&Milan 2008), the
pathway can also repress the cell cycle (Duman-Scheel
et al. 2004). The same is true for apoptosis, where Wg/
Arm signalling can activate (Cox et al. 2000, Lin et al.
2004) or repress (Cox et al. 2000, Giraldez & Cohen
2003) programmed cell death. In some contexts, such as
the developing wing, Wg acts as a morphogen, activat-
ing distinct targets in a concentration dependent manner
(Zecca et al. 1996, Neumann & Cohen 1997). Since
most transcriptional targets of Wg/Arm signalling are
regulated in a cell-type (Lee & Frasch 2000, Knirr &
Frasch 2001) or temporally restricted manner (Heems-
kerk et al. 1991), it is not surprising the the pathway can
effect different cells in dramatically different ways.
The following sections summarize some of the vast
literature covering Wnt/b-catenin signalling in develop-
ment, spanning the entire metazoan clade. Understand-
ing the molecular basis for the specificity of
transcriptional outcome in these different systems
requires a detailed understanding of how stabilized
b-catenin regulates gene expression, and this review
discusses the field’s progress towards realizing this
challenging goal.
Wnt/b-catenin signalling in establishing the primary body
axes of metazoans
Wnts and b-catenin are not found in choanoflagellates
(King et al. 2008), but are present in all metazoans.
Three Wnt genes are found in the demosponge
Amphimedon queenslandica (Adamska et al. 2010)
and four Wnt genes are present in the Mnemiopsis
leidyi genome (Pang et al. 1999). The sea anemone,
Nematostella vectensis has 14 Wnt genes, including 12
of the 13 subgroups found in mammals (Kusserow et al.
2005). This suggests a radiation of the Wnt family after
the cnidarian/bilaterian common ancestor diverged
from sponges and ctenophores. For a more comprehen-
sive list of Wnt gene number across metazoan evolution
see (Lengfeld et al. 2009).
The expression patterns of Wnts in simple metazoans
are highly suggestive of important roles in development.
In Amphimedon larvae Wnt is expressed at the posterior
end (Adamska et al. 2010). In Hydra, Wnt3 is expressed
at the prospective oral pole of embryos and larvae,
which will give rise to the head of the adult (Hobmayer
et al. 2000, Plickert et al. 2006, Duffy et al. 2010). In
Nematostella embryos, Wnts are expressed in overlap-
ping patterns along the anterior/posterior (A/P) axis,
suggesting that they provide positional information
along the primary body axis (Kusserow et al. 2005).
The expression of the four ctenophore Wnts in com-
plementary dynamic patterns during embryogenesis also
suggests important developmental roles in this organism
(Pang et al. 1999).
In addition to the presence of Wnts, simple metazoans
possess most of the downstream signalling components
identified in bilaterians. For example, sponges, cteno-
phores and cnidarians all contain one gene encoding
b-catenin, GSK3 and TCF, which are well conserved
with those in other metazoans. Consistent with the
existence of a functional Wnt/b-catenin pathway, appli-
cation of GSK3 inhibitors, well known to stabilize
b-catenin and TCF transcriptional readouts in mamma-
lian cell culture (Cohen & Goedert 2004), produce
dramatic phenotypes in these organisms. In sponges,
GSK3 inhibition leads to ectopic formation of ostia
(canal openings), which can disrupt feeding (Lapebie
et al. 2009, Windsor & Leys 2010). GSK3 inhibition in
Hydra produces multiple head and tentacles along the
body (Broun et al. 2005, Muller et al. 2007, Duffy et al.
2010). In the marine cnidarianHydractina echinata, this
multiple head phenotype is suppressed by RNAi deple-
tion of TCF (Duffy et al. 2010). In Hydra, depletion of
b-catenin results in loss of head structures, opposite to
the phenotype obtained with GSK3 inhibition (Gee
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et al. 2010). These results indicate that the basic
outlines of the pathway in these organisms are likely
operating in a similar fashion to that outlined in Fig. 1.
The direct transcriptional targets of Wnt/b-catenin
signalling in these simple systems are currently not
known but one candidate in cnidarians is the Brachyury
gene, known to be a direct target of Wnt3a signalling in
mouse embryos (Yamaguchi et al. 1999). In Hydracti-
na, Brachyury is expressed at the oral pole (like Wnt3a)
and is upregulated by GSK3 inhibition and downregu-
lated by Wnt3a and TCF depletion (Duffy et al. 2010).
In addition, this report provided evidence that Wnt3
and TCF are positively regulated by the pathway in
Hydractina (Duffy et al. 2010). Regulation of TCFs by
the Wnt/b-catenin pathway is also found in mammalian
systems (Hovanes et al. 2001). Autoregulation of Wnt
gene expression by the pathway is also likely in Hydra,
where in addition to Wnt3 (Hobmayer et al. 2000) six
other Wnt genes are expressed at the oral end of the
organism (Lengfeld et al. 2009). During head regener-
ation, expression of Wnt3 precedes the other Wnts,
suggesting that they may be activated by Wnt3 signal-
ling (Lengfeld et al. 2009).
In bilaterians, there is also abundant evidence that
Wnt/b-catenin signalling is critical for axial patterning.
In Planaria, depletion of b-catenin results in additional
head structures in posterior regions (Gurley et al. 2008,
Iglesias et al. 2008, Petersen & Reddien 2008). The
pathway is also required for the formation of posterior
structures in mouse embryos (Liu et al. 1999, Yamag-
uchi et al. 1999, Huelsken et al. 2000, Kelly et al.
2004) and Wnt/b-catenin signalling plays a similar role
in specifying cell identities along the A/P axis of the
CNS of Xenopus (Niehrs 2010). When one considers
that the oral pole of cnidarians likely corresponds to the
posterior end of the body plan (Meinhardt 2002, Guder
et al. 2006, Niehrs 2010), it appears that the role of
high levels of Wnt/b-catenin signalling in promoting
posterior identity may be very ancient and predate the
split between cnidarians and bilaterians (Petersen &
Reddien 2009, Niehrs 2010) (Fig. 3).
Two notable exceptions to the global role for Wnt/
b-catenin signalling in establishing the A/P body axis
are Drosophila and Caenorhabditis elegans. In flies,
Wg/Arm signalling is involved in establishing A/P
identity in each segment (Sanson 2001), while the
maternally provided transcription factor Bicoid is a
major determinant of global A/P patterning (Porcher &
Dostatni 2010). This is likely the result of the high
degree of specialization that has occurred in dipteran
evolution (Riechmann & Ephrussi 2001) and the role of
Wnt/b-catenin signalling in other insects is similar
to other metazoans [reviewed in (Niehrs 2010)]. In
C. elegans, asymmetric cell divisions (mostly along the A/P
axis) are controlled by the Wnt/b-catenin/asymmetry
pathway, in which two b-catenin proteins (WRM-1 and
SYS-1) act through distinct mechanisms to regulate the
TCF family member POP-1. WRM-1 promotes POP-1
nuclear efflux while SYS-1 acts in a similar manner as
b-catenin/Arm (Mizumoto & Sawa 2007). It is not clear
how the five C. elegans Wnts can provide positional
information to regulate all the asymmetric cell divisions
controlled by POP-1, but there is evidence that tran-
siently expressed Wnt (MOM-2) in posterior blasto-
meres can maintain A/P polarity in other cells through a
Wnt-dependent relay mechanism (Bischoff & Schnabel
2006). While the rapid generation time and stripped
down genomes of Drosophila and C. elegans have made
them powerful genetic systems for understanding the
molecular basis of development (including Wnt/b-catenin
signalling) it appears that their overall developmental
strategies for axial patterning have diverged from the
general metazoan scheme.
Wnt/b-catenin signalling in establishing the A/P axis of
vertebrates
In addition to the Wnt/b-catenin pathway forming a
gradient of Wnt signalling along the A/P axis, a gradient
of BMP signalling along the dorsal/ventral (D/V) axis is
found in a wide array of bilaterians. Niehrs (2010) has
proposed a Cartesian coordinate system of Wnt and
BMP signalling to control bilaterian body axes. In
Xenopus embryogenesis, these perpendicular gradients
are initiated by the Spemann organizer (De Robertis &
Kuroda 2004, Vonica & Gumbiner 2007). Maternally
providedWnt5a andWnt11 (Tao et al. 2005, Cha et al.
2008) and other Wnt signalling components (White &
Heasman 2008) are relocated to the future dorsal side
of the embryo opposite to sperm entry. Wnt/b-catenin
signalling then activates the expression of two homeo-
domain transcription factors, Siamois and Twin, which
establish organizer identity (Ishibashi et al. 2008).
Analysis of the regions upstream of the twin and
siamois transcription start sites (TSSs) demonstrated the
existence of functionally important binding sites for
TCFs (Brannon et al. 1997, Laurent et al. 1997, Fan
et al. 1998), which is supported by more recent data
with chromatin immunoprecipitation (ChIP) of TCF3
(Hikasa et al. 2010). Siamois, Twin and Wnt/b-catenin
signalling then act together to activate expression of a
variety of BMP antagonists, which emanate from the
organizer to set up a gradient of BMP4 signalling
activity across the D/V axis (De Robertis & Kuroda
2004, Vonica & Gumbiner 2007).
In addition to expressing BMP antagonists, the
Spemann organizer also expresses antagonists of Wnt/
b-catenin signalling, such as Dickkopf1 (Dkk1), Cer-
berus and secreted frizzled related protein 2 (sFRP2).
Dkk1 is thought to be directly activated by TCF and
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b-catenin (Chamorro et al. 2005), while Cerberus and
sFRP2 are Siamois-dependent (Engleka & Kessler 2001,
Yamamoto et al. 2003a). These Wnt antagonists con-
tribute to a Wnt/b-catenin signalling gradient with the
highest Wnt signalling in the posterior (De Robertis &
Kuroda 2004, Vonica & Gumbiner 2007). Overexpres-
sion of Dkk1 (decreasing signalling levels) expands
anterior structures and morpholino depletion of Dkk1
(increasing signalling levels) results in reduced anterior
identity (Niehrs 2006). Consistent with this, disruption
of the mouse Dkk1 gene results in embryos with a loss
of head (Mukhopadhyay et al. 2001). In Hydra, Wnt/b-
catenin signalling inhibits Dkk expression, indicating
the existence of an ancient Wnt-Dkk axial patterning
circuit (Guder et al. 2006, Niehrs 2010).
Neural crest: cross-regulation facilitates Wnt-dependent
context specificity
One outcome of the Wnt/b-catenin signalling gradient
in vertebrates is the induction of the neural crest (NC).
In Xenopus, low BMP4 signalling and other signals in
the dorsal portion of the embryo are required for
induction of the neural plate (Stern 2005). After the
neural plate invaginates to form the neural tube, NC
cells are specified near the dorsal–lateral portion of the
neural tube (Barembaum& Bronner-Fraser 2005). Wnt/
b-catenin signalling is required for this induction, and
the Wnt3a expressed in the overlying epidermis appears
to be the ligand (McGrew et al. 1997, Li et al. 2009).
The gradient of Wnt signalling from the posterior of the
embryo is required to prevent NC induction in the
anterior neural fold (Li et al. 2009). After specification,
NC cells migrate to different locations to differentiate
into a diverse array of tissues, including facial cartilage,
bones and smooth muscle cells of the heart (Sauka-
Spengler & Bronner-Fraser 2006).
How Wnt/b-catenin signalling induces the NC is
being elucidated in detail. There are over a dozen
transcription factors that have been shown to be
required for specification of the NC cell fate (Barem-
baum & Bronner-Fraser 2005, Sauka-Spengler &
(a)
(b)
Figure 3 Wnt/b-catenin signalling in establishing the metazoan A/P axis. (a) Some of the circuitry involved in establishing the A/P
axis in Xenopus. Maternal Wnt11 and Wnt5a act through b-catenin to directly activate the Spreman organizer genes siamois and
twin (Brannon et al. 1997, Laurent et al. 1997, Fan et al. 1998, Tao et al. 2005, Cha et al. 2008). Wnt/b-catenin signalling also
activates expression of Dkk1 (Chamorro et al. 2005), and Siamois and Twin are thought to activate cerberus and sFRP expression
(Engleka & Kessler 2001, Yamamoto et al. 2003a). These three Wnt antagonist suppress pathway activation in dorsal/anterior
structures, allowing anterior structures to form (Niehrs 2006). See the text for more details. (b) Cartoon of an amphibian tadpole or
regenerating Planaria, illustrating the Inhibition of Wnt/b-catenin signalling promotes an anterior identity, while expression of
Wnt3a promotes a posterior identity (centre column). Expression of Wnt antagonists in Xenopus or reduction of b-catenin activity
in Planaria causes an expansion of anterior structures at the expense of posterior structures (Niehrs 2006, Petersen & Reddien
2009). Conversely, inappropriate activation of Wnt/b-catenin signalling caused loss of anterior structures. See text for further
explanation. A/P, anterior/posterior.
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Bronner-Fraser 2006). The expression of many of these
genes has been shown to be Wnt-dependent, but they
also cross-regulate each other, making it difficult to
identify the direct targets of the Wnt/b-catenin pathway.
Recently, two reports have used a combination of
approaches to provide evidence that Gbx2 and Meis3
are important direct Wnt targets in NC induction in
Xenopus (Li et al. 2009, Elkouby et al. 2010). Hor-
mone-inducible versions of TCF or b-catenin (fused to
the glucocorticoid receptor) demonstrated activation in
the absence of protein synthesis. An enrichment of
b-catenin at the regulatory regions of these genes was
demonstrated via ChIP. Finally, predicted TCF sites in
the regulatory regions were mutated, leading to a loss of
reporter gene expression (Li et al. 2009, Elkouby et al.
2010). These results argue that these genes are direct
targets of the pathway.
Consistent with the above data, Gbx2 morphants
display a loss of many NC markers (Li et al. 2009).
Depletion of Meis3 has a similar phenotype, including
a reduction in Gbx2 expression (Elkouby et al. 2010).
Meis3 is clearly a major target of Wnt/b-catenin
signalling, because exogenous addition of the Meis3
gene can rescue the loss of NC seen in Wnt3a
morphants (Elkouby et al. 2010). These studies suggest
that Wnt/b-catenin signalling initially induces both
Meis3 and Gbx2, and Meis3 contributes to Gbx2
expression. In a similar manner, Slug 2 is directly
activated by the Wnt/b-catenin pathway (Vallin et al.
2001) but also requires Meis3 and Gbx2 for expres-
sion (Li et al. 2009, Elkouby et al. 2010). In addition,
Gbx2 is a transcription repressor, which inhibits the
expression of anterior neural fold markers such as
Six1, restricting NC induction to posterior regions
(Fig. 4).
The cross-regulation of Wnt targets Meis3 and Gbx2
is one illustration of the complex regulatory networks
that are found in development. Such cross-regulation
can also occur between the TCF-b-catenin complex and
its targets. Wnt3a is essential for posterior axial growth
in mice (Yamaguchi et al. 1999, Aulehla et al. 2003,
Dunty et al. 2008). A similar loss of caudal structures is
observed when combinations of the caudal homeobox
genes (Cdx1, Cdx2 or Cdx4) are mutated in mice or
zebrafish (Shimizu et al. 2005, Davidson & Zon 2006,
Young et al. 2009). Cdx genes are activated by Wnt/
b-catenin signalling (Ikeya & Takada 2001, Gaunt
et al. 2003) and in some cases this regulation is direct
(Lickert et al. 2000, Ikeya & Takada 2001, Pilon et al.
2006). However, Wnt3a expression also requires Cdx
activity, and loss of function Cdx2 and Cdx4 pheno-
types can be rescued by an activated version of LEF1
(Young et al. 2009). A similar positive feedback loop
between Wnt and Cdx has also been reported to be
required for posterior development in Xenopus (Faas &
Isaacs 2009). Interestingly, Cdx1 autoregulation has
been reported to require a physical interaction between
LEF1 and Cdx1 (Beland et al. 2004), providing a clue as
to how TCF family members and Cdx proteins act
together. A similar relationship has been demonstrated
between the Wnt target Brachyury and the Wnt/
b-catenin pathway in promoting posterior mesoderm
development (Martin & Kimelman 2008).
Cardiogenesis: reiterative Wnt/b-catenin signalling
required
Beyond helping establish the basic body plan, Wnt/
b-catenin signalling is important for a multitude of
developmental decisions. These include limb formation,
bone, hair and teeth development as well as formation
of every major organ (see (Grigoryan et al. 2008) for a
comprehensive review of b-catenin-dependent develop-
mental processes in mice). In this review, we will focus
on heart formation, which provides a good example of
how the Wnt/b-catenin pathway is used repeatedly to
achieve different outcomes in different developmental
contexts, even in the same tissue. Further information
on the role of canonical and non-canonical Wnt
signalling in heart development can be found in
additional reviews (Cohen et al. 2008, Kwon et al.
2008, Gessert & Kuhl 2010).
Although the tube-like insect heart is morphologically
different from the multichambered vertebrate heart,
they appear to share a common ancestry. One striking
example supporting this view is provided by the tinman/
Nkx2.5 gene, which is required for heart formation in
Drosophila and several vertebrate systems (Bodmer &
Venkatesh 1998, Evans 1999). In flies, Wg/Arm signal-
ling is required for tinman expression and heart
Figure 4 Wnt/b-catenin signalling induces neural crest. Wnt3a
from the overlying epidermis induces expression of Meis3 and
Gbx2 are induced in the neural tube (Li et al. 2009, Elkouby
et al. 2010). Meis3 also cross regulates Gbx2 (Elkouby et al.
2010) and Slug2 is activated by a combination of Wnt3a, Gbx2
and Meis3 (Vallin et al. 2001, Li et al. 2009, Elkouby et al.
2010). See text for further information.
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formation in general (Wu et al. 1995, Park et al. 1996).
In contrast, the first studies in vertebrates found that
Wnt/b-catenin signalling is required to restrict specifi-
cation of cardiac mesoderm (Marvin et al. 2001,
Schneider & Mercola 2001, Lickert et al. 2002).
This paradox between invertebrate and vertebrates
has been resolved by the realization that the Wnt/
b-catenin pathway plays two opposing roles in early
vertebrate cardiogenesis. Temporal control of Wnt
expression revealed that before gastrulation, the path-
way activates Nkx2.5 expression in zebrafish embryos
(Ueno et al. 2007). After gastrulation, the previously
described inhibitory role was evident. This biphasic
relationship was also observed in mouse ES cells, which
spontaneously differentiate into cardiomyocytes. Acti-
vation of Wnt/b-catenin signalling in early cultures
dramatically enhanced cardiomyoctes differentiation
but pathway activation in later cultures reduced car-
diogenesis (Ueno et al. 2007). These data suggest that
the initial pro-cardiogenic effect of the Wnt/b-catenin
pathway in vertebrates is analogous to the positive
effect that Wg/Arm signalling has on heart development
in the fly.
What are some of the direct targets in the initial
regulation of cardiogenesis by the pathway? In flies, the
presence of functional TCF binding sites in the enhanc-
ers that drive the expression of the transcription factors
Sloppy paired 1 (Slp1) and Even-skipped (Eve) in the
cardiac precursors provides strong evidence that these
genes are directly activated by Wg/Arm signalling
(Halfon et al. 2000, Lee & Frasch 2000, Knirr &
Frasch 2001, Han et al. 2002). In mouse ES cells, gene
profiling revealed many potential targets, including
Brachyury, Mesp1 and Sox17 (Liu et al. 2007, Ueno
et al. 2007). In regard to repression of cardiogenesis, the
homeodomain protein Hex is an important Wnt target
that is repressed in the presumptive cardiac mesoderm
(Foley & Mercola 2005). In Xenopus, GATA6 expres-
sion is repressed by Wnt/b-catenin signalling, and forced
expression of GATA6 is sufficient to rescue many
aspects of heart development that are disrupted by
ectopic Wnt pathway activation (Afouda et al. 2008).
The mechanism by which these genes are repressed by
Wnt/b-catenin signalling is not known.
After the initial specification of the presumptive heart
field, a population of cardiomyocytes known as the
secondary heart field (SHF) will give rise to the future
right ventricle and inflow and outflow tracts of the heart
(Dyer & Kirby 2009). Conditional knockout of b-cate-
nin causes a significant reduction in these structures (Ai
et al. 2007, Cohen et al. 2007, Klaus et al. 2007, Kwon
et al. 2007, Tian et al. 2010). Removal of b-catenin
before SHF specification resulted in a loss of Islet1 (a
LIM homeodomain) expression, a marker of SHF
cells (Cai et al. 2003). There is some evidence to
indicate that the activation of Islet1 transcription by
Wnt/b-catenin signalling is direct (Lin et al. 2007).
Later removal of b-catenin in the developing SHF
resulted in normal Islet1 expression, but the right
ventricle and outflow tracts still failed to form (Ai et al.
2007, Kwon et al. 2007). These results indicate multiple
roles for Wnt/b-catenin signalling in SHF development,
both in establishing the SHF and subsequent differen-
tiation of heart tissue.
The complexity of target gene regulation by the Wnt/
b-catenin pathway in the development of the secondary
heart filed is evidenced by the findings that Wnt/b-
catenin signalling represses Islet1 expression in differ-
entiating cardiomyocytes (Kwon et al. 2009). Likewise,
GATA6, which is repressed by Wnt/b-catenin signalling
in early heart development in Xenopus (Afouda et al.
2008), is directly activated by Wnt/b-catenin signalling
in the posterior SHF (Tian et al. 2010). The factors that
enable the same pathway to both activate and repress
the same targets during the cardiomyocyte cell lineage
are not known.
There are several additional events in heart develop-
ment where Wnt/b-catenin signalling is also required.
Mutations lowering pathway activity in cardiac NC cells
result in defects to the cardiac outflow tract (Hamblet
et al. 2002, Kioussi et al. 2002). This phenotype is
similar to that observed when the gene encoding the
bicoid homeodomain protein PitX2 is mutated (Kioussi
et al. 2002). PitX2 is directly activated by LEF1 and b-
catenin and then PitX2 subsequently recruits b-catenin
to the Cyclin D2 regulatory region, activating this cell
cycle regulator and promoting proliferation of the
cardiac NC cells (Kioussi et al. 2002). The Wnt/b-
catenin pathway also promotes endocardial cell prolif-
eration, which contributes to heart valve formation
(Gitler et al. 2003, Hurlstone et al. 2003, Liebner et al.
2004, Alfieri et al. 2010). Likewise, loss of b-catenin in
the developing epicardium results in defects in coronary
artery formation (Zamora et al. 2007).
Heart development highlights the multiple roles that
the Wnt/b-catenin pathway plays in regulating cell fate
and organogenesis (Fig. 5). How can one signalling
pathway be utilized so many times to regulate different
genes in the cardiac cell lineage? Understanding how
Wnt transcriptional output diversity is generated
requires a more detailed understanding of how TCF
family members and other transcription factors that
mediate Wnt/b-catenin-dependent gene regulation func-
tion on target gene chromatin.
Wnt/b-catenin signalling in stem cell biology
and regeneration
In addition to the myriad roles that the Wnt/b-catenin
pathway plays in normal development, it is also a key
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regulator of adult tissue homeostasis. The role of Wnt/
b-catenin signalling in stem cell maintenance has been
well documented in the intestine (Pinto & Clevers 2005,
Barker & Clevers 2010), hair follicles and in the skin
(Blanpain et al. 2007, Blanpain & Fuchs 2009, Haege-
barth & Clevers 2009). In the mouse small intestine,
TCF4 and b-catenin are required for maintenance of the
crypt stem cells (Pinto & Clevers 2005). Microarray
profiling has identified many transcriptional targets of
the Wnt/b-catenin pathway (van de Wetering et al.
2002, Van der Flier et al. 2007). One biologically
important target is c-myc, which is required for normal
intestinal crypt development (Muncan et al. 2006). As
will be discussed in the following section, c-myc appears
to be a direct target of the pathway. Another gene that is
activated by Wnt/b-catenin signalling encodes the
orphan receptor Lgr5, which has received a great deal
of attention, since it marks a population of multipotent
cells in the crypt that give rise to all the specialized cells
of the intestinal epithelia (Barker & Clevers 2010).
Another biologically important Wnt target is the bHLH
transcription factor Achaete scute-like 2 (Ascl2), which
is required for the maintenance of the Lgr5-positive
stem cells and can induce crypt hyperplasia upon forced
expression (van der Flier et al. 2009). Both Lgr5 and
Ascl2 were identified in a genome-wide survey of
chromatin enriched for TCF4 binding (Hatzis et al.
2008), suggesting they may be direct targets of Wnt/b-
catenin signalling. In addition to intestinal stem cells,
Lgr5 and the related protein Lgr6 also appear to mark
stem cells populations in several other organs as well
(Haegebarth & Clevers 2009, Snippert et al. 2010).
Wnt/b-catenin signalling has also been linked to the
ability to replace damaged cells or to regenerate deleted
tissues in a wide array of metazoans. In Hydra and
Planaria, organisms renowned for their ability to
regenerate large portions of their bodies after bisection,
the pathway promotes posterior cell fates as described
in the previous section. In Hydra, decapitation of the
head results in rapid induction of Wnt3 expression in
the epithelial cells which is required for head regener-
ation (Hobmayer et al. 2000, Chera et al. 2009, Leng-
feld et al. 2009). When Hydra is bisected in the
midgastric region, a wave of apoptosis among the
interstitial cells is coupled to release of Wnt3 from these
dying cells, which results in subsequent activation of
Wnt3 transcription in epithelial and head regeneration
(Chera et al. 2009, Galliot & Chera 2010).
The coupling of apoptosis to generation of a Wnt
signal in regenerating Hydra is reminiscent of a similar
phenomenon described in Drosophila imaginal discs,
where apoptotic cells express Wg, which is thought to
promote compensatory proliferation of neighbouring
cells to maintain the size of the tissue (Fan & Bergmann
2008, Martin et al. 2009). While Wg is dispensable for
disc repair in response to irradiation (Perez-Garijo et al.
2009), a functional role for Wg has been reported in
disc regeneration following expression of a pro-apop-
totic signal, where Wg induced expression of myc and
cyclin E to promote proliferation (Smith-Bolton et al.
2009).
In vertebrates, Wnt/b-catenin signalling has been
shown to be required for tail fin regeneration in zebrafish
(Stoick-Cooper et al. 2007).Wnt10a is induced after fin
cutting, and blocking the pathway prevents induction of
fibroblast growth factor 20a (fgf20a) expression, which
is required for regeneration of this tissue (Wills et al.
2008). Interestingly, fgf20a is directly activated by TCF-
b-catenin in cultured human cells (Chamorro et al.
2005), though it is not clear whether this is the case in
regenerating zebrafish tails. The pathway is also thought
Figure 5 Wnt/b-catenin signalling (Wnt/b-cat) has multiple
roles in heart development. This schematic depicts a few of the
roles the pathway plays in mammalian heart development,
both as an activator and as a repressor of gene activity. Prior to
gastrulation, nkx2.5 is positively activated by Wnt/b-cat
signalling, while it is repressed after gastrulation, as are
cardiogenic factors GATA6 and Hex (Foley & Mercola 2005,
Ueno et al. 2007, Afouda et al. 2008). Activation of a number
of Wnt target genes early in development, such as Islet1 have
been linked to the proliferation of cardiac progenitor cells (Lin
et al. 2007). These Islet1+ cells contribute to the second heart
field (SHF), inflow tract (IFT) and outflow tract (OFT). The
SHF is required for proper formation of the atria and the right
ventricle. In the posterior SHF, Wnt activates GATA6 (Tian
et al. 2010), and represses Islet1 expression (Kwon et al.
2009). Wnt/b-cat signalling is also instrumental in driving
proliferation of cardiac neural crest cells (Kioussi et al. 2002),
which migrate to the heart tube and OFT, and is important in
valve and artery formation (Zamora et al. 2007) along with
endocardial proliferation (Gitler et al. 2003, Hurlstone et al.
2003, Liebner et al. 2004, Alfieri et al. 2010). See text for more
information. FHF, first heart field.
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to play a role in the initial step of limb regeneration in
Xenopus (Yokoyama et al. 2007), though the molecular
targets remain to be identified.
Wnts gone wrong: misregulated signalling in
disease
Given the numerous functions of Wnt/b-catenin signal-
ling in development and stem cell biology, it is not
surprising that misregulation of the pathway would be
connected to a large number of diseases. Activation of
Wnt/b-catenin signalling has been linked to many
different types of human cancer, including colorectal
cancer (CRC) (Polakis 2000, 2007), hepatocellular
carcinomas (Armengol et al. 2009), cancers of the
adrenal gland (El Wakil & Lalli 2011, Morris et al.
2010), Wilm’s tumour (Tycko et al. 2007), breast
cancer (Zardawi et al. 2009) and several hematological
malignancies (Ge & Wang 2010). In some cancers, for
example, melanoma, down-regulation of the pathway
leads to more aggressive malignancy (Lucero et al.
2010). Many of these cancers contain either loss-
of-function mutations in the APC gene, causing stabil-
ization of b-catenin, or gain-of-function mutations in
b-catenin, which interfere with phosphorylation of
b-catenin by the destruction complex (Polakis 2000,
2007). Loss of Axin or Axin2 is also correlated with
some forms of cancer (Laurent-Puig & Zucman-Rossi
2006). In the next section, we focus on the role of c-myc
activation by the Wnt/b-catenin pathway, because of
the biologically relevance of this regulation in cancer,
and as an example of how difficult it can be to identify
all the DNA regulatory sequences that mediate Wnt
responsiveness (i.e. WRE) of a target gene.
CRC: activation of c-myc expression by the Wnt/b-catenin
pathway
The c-myc gene encodes a basic helix-loop-helix
(bHLH) protein that promotes cell growth in many cell
types (Soucek & Evan 2010). Elevated expression of
c-myc has been linked to numerous human cancers
(Eilers & Eisenman 2008). c-myc expression is activated
by Wnt/b-catenin signalling in CRC cells (He et al.
1998, van de Wetering et al. 2002) and in the exper-
imentally induced murine epithelial hyperplasia associ-
ated with temporally controlled deletion of APC
(leading to b-catenin stabilization) (Sansom et al.
2004). Strikingly, simultaneous loss of APC and c-myc
in this system completely suppressed the overgrowth
phenotype caused by APC removal, even though
b-catenin levels were still abnormally high (Sansom
et al. 2007). Microarray analysis suggests that many of
the changes in gene expression observed upon removal
of APC are c-myc dependent (Sansom et al. 2007),
indicating that c-myc is a major factor in mediating the
effect of elevated Wnt/b-catenin signalling in the intes-
tinal epithelia.
When c-myc was first identified as a potential
transcriptional target of the Wnt/b-catenin pathway in
CRC, examination of the region 5¢ of the TSS revealed
the presence of conserved TCF binding sites (He et al.
1998). This region of DNA could activate a minimal
promoter/luciferase reporter upon Wnt/b-catenin path-
way activation and thus fits the definition of a WRE.
Mutation of two TCF binding sites within this WRE
abolished this activation (He et al. 1998). ChIP studies
demonstrated that this region was bound by LEF1 and
b-catenin in CRC cells (Sierra et al. 2006). More
recently, another site enriched for b-catenin binding in
CRC cells was identified downstream of the c-myc
transcription unit (Yochum et al. 2008). This region
also conferred Wnt responsiveness in a reporter gene
assay and contained functionally important TCF sites
(Yochum et al. 2008). Chromatin loops between these
two WREs and the c-myc proximal promoter have been
reported (Yochum et al. 2010).
While, the data described above suggest that the
WREs identified 5¢ and 3¢ of the c-myc gene contribute
to regulation by Wnt/b-catenin signalling, the large
intergenic regions surrounding this Wnt target raised
the possibility of other WREs further removed from the
TSS (Fig. 6). Indeed, when a genomic fragment con-
taining the 5¢ and 3¢ WREs were tested in a transgenic
mouse reporter assay, there was little transcriptional
activity observed (Lavenu et al. 1994). An in silico
search for WREs identified two regions approx. 26 and
36 kb upstream of the c-myc TSS (Hallikas et al. 2006).
Both regions drove the expression of a reporter in
transgenic mice in a subset of the c-myc pattern, though
it is not clear whether these elements are regulated by
Wnt/b-catenin signalling (Hallikas et al. 2006).
Another potentially important WRE controlling
c-myc has been identified through genome-wide associ-
ation scans for polymorphisms that increase an indi-
vidual’s risk of developing CRC (Tomlinson et al. 2007,
Zanke et al. 2007). A single nucleotide polymorphism
(G/T; known as rs6983267) was linked with an
increased occurrence of adenomas and CRC. While
control populations had an approximate 50/50 distri-
bution of the G and T allele, the G allele was found at
approx. 56% in affected individuals (Tomlinson et al.
2007, Zanke et al. 2007). This polymorphism is located
approx. 335 kb upstream of the c-myc TSS (Fig. 6).
The realization that this polymorphism occurs in a
putative TCF binding site (GATGAAAGG vs. GAT-
GAAAGT) suggested that this polymorphism resides
within a WRE controlling c-myc expression. Consistent
with this, TCF4 was highly enriched at this site
compared to the other 1 Mb of DNA surrounding the
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c-myc locus (Tuupanen et al. 2009). This region had
WRE activity in cell culture reporter assays (Pomerantz
et al. 2009, Tuupanen et al. 2009, Sotelo et al. 2010,
Wright et al. 2010). More impressively, this region
drove expression of a reporter in transgenic mouse
embryos in a pattern very similar to the majority of
endogenous c-myc expression, which was abolished by
mutation of the polymorphic TCF site and an adjacent
site (Tuupanen et al. 2009). Consistent with the
increased risk of CRC, the G allele WRE had a greater
response to Wnt/b-catenin pathway activation in cell
culture reporter assays (Pomerantz et al. 2009, Tuupa-
nen et al. 2009, Wright et al. 2010). When a CRC cell
line with a G/T genotype was examined, TCF4 and
b-catenin were enriched on the G allele chromatin, and
this allele was more than two times more actively
transcribed than the T allele (Wright et al. 2010). Taken
together, these data support a model where increased
recruitment of TCF4 and b-catenin to the G allele WRE
results in higher levels of c-myc transcription. A chro-
matin loop between this distal WRE and the c-myc
proximal promoter has been demonstrated (Pomerantz
et al. 2009, Wright et al. 2010), suggesting a mecha-
nism by which this element can act over such a great
distance (Fig. 6B).
The regulation of c-myc by the Wnt/b-catenin path-
way illustrates an inconvenient truth about studying
gene regulation in higher eukaryotes. The existence of a
WRE over 300 kb from the c-myc TSS should no longer
cause surprise, given the existence of functional ele-
ments acting at an even greater distance in regulating
sonic hedgehog (Jeong et al. 2006). In addition, there is
a growing realization that the majority of developmen-
tally regulated enhancers are more than 100 kb away
from the nearest TSS (Visel et al. 2009). The ability to
scan the large regions of genome surrounding Wnt
targets of interest may often be necessary to identify
some functionally important WREs.
Wnts and oxidative stress: diabetes and Alzheimer’s
disease
In addition to cancers, the Wnt/b-catenin pathway has
been linked to many other diseases, including several
pathologies in the kidney (Pulkkinen et al. 2008,
Hwang et al. 2009, Lancaster & Gleeson 2010), bone
(Krishnan et al. 2006) and cardiac repair (Saraswati
et al. 2010). In this section, we briefly review the role of
Wnt/b-catenin signalling in metabolic disorders and
neurodegenerative diseases. While the direct links
between these disorders and Wnt/b-catenin signalling
are not as well established as in cancer, there are some
candidate targets where misregulation of the pathway
could underlie the pathology.
Emerging evidence has linked several players in Wnt/
b-catenin signalling to metabolic disorders and type 2
diabetes mellitus. Genome-wide association studies
demonstrated a strong connection between diabetes
type 2 risk and SNPs within the TCF7L2 (TCF4) gene,
although the cellular basis of this association is still
uncertain (Schinner et al. 2009). Mutations in the Wnt
receptors LRP5 and 6 have also been implicated in
obesity and type 1 diabetes and metabolic syndrome
respectively (Jin 2008). Wnt/b-catenin signalling
appears to play roles both in the proliferation of
pancreatic b-cells, and in the insulin release from islet
(a)
(b)
Figure 6 Complex regulation of the Wnt target gene c-myc. (a) WREs are located both near and removed from the c-myc proximal
promoter. The numbers in parentheses refer to the approximate position of the 5¢ end of the WRE in relation to the c-myc TSS.
The 5¢ ()1.2 kb) and 3¢ (+5.5 kb) WREs respond to Wnt/b-catenin signalling in cell culture (He et al. 1998, Yochum et al. 2008).
The far upstream ()335 kb) WRE is active in cell culture and transgenic mice (Tuupanen et al. 2009) and contains a polymorphism
in a TCF binding sites that correlated with increased risk of CRC (Pomerantz et al. 2009, Tuupanen et al. 2009, Wright et al.
2010). The putative WREs at )26 kb and )32 kb are expressed in transgenic mice (Hallikas et al. 2006). (b) The presence of
chromatin loops between the far upstream and the 3¢ WRE have been documented in CRC cells with high levels of Wnt/b-catenin
signalling (Pomerantz et al. 2009, Wright et al. 2010, Yochum et al. 2010). These loops are stabilized by protein complexes (data
not shown) containing TCF and b-catenin. Presumably, the large chromatin loop allows the upstream enhancer to bypass the
POU5F1 gene, though this has not been experimentally confirmed. WRE, Wnt response elements; TSS, transcription start sites;
TCF, T-cell factor; CRC, colorectal cancer.
84
 2011 The Authors
Acta Physiologica  2011 Scandinavian Physiological Society, doi: 10.1111/j.1748-1716.2011.02293.x
Wnt/b-catenin transcriptional regulation Æ H C Archbold et al. Acta Physiol 2012, 204, 74–109
cells. b-cell proliferation in cell culture and a transgenic
mouse models appears to be the result of Wnt activation
of targets like cyclin D1 (Liu & Habener 2008, Schinner
et al. 2008), as well as cyclin D2 and PitX2 (Rulifson
et al. 2007). Consistent with this, knockdown of TCF4
decreases b-cell proliferation and promotes apoptosis
(Liu & Habener 2008, Shu et al. 2008).
In addition to promoting b-cell proliferation, the
Wnt/b-catenin pathway is also required for efficient
insulin secretion (Fujino et al. 2003). The pathway may
play a role in insulin sensing by activating glucokinase
transcription (Schinner et al. 2008). It is interesting to
note that antagonism of Wnt signalling by oxidative
stress appears to play an important role in the pathology
of insulin resistance and diabetes. The forkhead box
DNA-binding protein FOXO, has been shown to
compete with TCFs for b-catenin binding (Hoogeboom
et al. 2008). Upregulation of FOXOs in response to
oxidative stress may contribute to insulin resistance by
the promotion of gluconeogenesis and/or the promotion
of apoptosis and downregulation of TCF-mediated gene
expression (Manolagas & Almeida 2007).
The effects of oxidative stress may also be a factor in
the neurodegeneration of Alzheimer’s disease (AD),
where Wnt signalling has been ascribed a neuroprotec-
tive role (Manolagas & Almeida 2007). Extracellular
accumulation of amyloid-b (A-b) has been shown to
bind Fz receptors and downregulate Wnt signalling, and
it has been hypothesized that some of the cytotoxity
caused by A-b may be the result of chronic suppression
of Wnt/b-catenin signalling (Inestrosa & Toledo 2008).
The protective effects of b-catenin overexpression, but
not of transcriptionally inactive b-catenin, indicate that
transcriptional activation of target genes plays a role in
ameliorating A-b toxicity (Chacon et al. 2008). One
possibility is that oxidative stress may exacerbate
cytotoxity in AD by increasing FOXO, which then
competes with TCF for b-catenin, reducing the expres-
sion of anti-apoptotic factors.
Clearly, much remains to be elucidated concerning
the role Wnt/b-catenin signalling plays in neurodegen-
eration and other diseases. Information gained from the
study of Wnt-mediated transcriptional regulation in
model systems should facilitate the identification of the
important targets in many pathological states where
genetics suggests that aberrant Wnt signalling plays a
causal role. Given the prominence of TCF family
members in regulating numerous Wnt targets, the next
few sections will review TCF function in detail.
The TCF family: major regulators of Wnt/b-
catenin transcription
The TCF family of transcription factors is the best
characterized DNA-binding regulators of Wnt/b-catenin
target gene expression. In addition to a b-catenin
binding domain at the N-terminus, a hallmark of this
family is the presence of a highly conserved HMG
domain, followed by a stretch of basic residues (Fig. 2).
The TCF subfamily of HMG domains is found through-
out metazoans, but not in the sister group choanofla-
gellates (King et al. 2008). The HMG domain contacts
DNA largely through minor groove contacts and results
in a large bending of the double helix (Love et al. 1995).
High affinity binding sites for these HMGs have been
determined for Drosophila TCF/Pangolin (TCF/Pan)
and all four mammalian TCFs (Giese et al. 1991, van de
Wetering et al. 1997, van Beest et al. 2000, Hallikas
et al. 2006, Atcha et al. 2007). While, these studies
show that a site of CCTTTGATS (S = G/C) is bound
with highest affinity in vitro, as will be described in the
following section, many functional TCF binding sites in
WREs fit this consensus, while others diverge markedly.
There is a single TCF gene in almost all invertebrate
species that have been examined thus far (Figs 2 and 6),
with TCF/Pan from flies and POP-1 from C. elegans
being the most thoroughly characterized. In contrast,
amphibians and mammals have four TCF genes. These
are most commonly referred to as TCF1 (TCF7), LEF1
(LEF1), TCF3 (TCF7L1) and TCF4 (TCF7L2). The
names in parentheses are from the Human Genome
Organization (HUGO). In zebrafish, the TCF7L1 gene
is duplicated (TCF7L1a and TCF7L1b), giving a total
of five TCF genes in bony fish (Dorsky et al. 2003). As
will be discussed below, there is evidence that some of
the vertebrate TCFs are more specialized in their
function compared to their invertebrate counterparts.
The TCF transcriptional switch
The current working model for regulation of WREs by
TCFs proposes the existence of a transcriptional switch,
where TCF and co-repressors inhibit the target gene
expression in the absence of signalling, and then act
with b-catenin and other co-activators to activate
transcription of targets (Fig. 1). Evidence for this model
was first obtained in the Drosophila embryo. TCF/pan
mutants display mispatterning of the epidermis indica-
tive of reduction of Wg signalling (Brunner et al. 1997,
van de Wetering et al. 1997, Schweizer et al. 2003).
This defect was not as severe as that of null alleles of
wg. However, a wg; TCF/pan double mutant looked
identical to TCF/pan mutants (Cavallo et al. 1998). In
wg mutants, there is no activation of targets and TCF
repression is intact, resulting in a severe loss of Wg
signalling phenotype. But in wg; TCF/pan double
mutants, loss of repression of Wg targets allows some
expression (i.e. derepression), resulting in a less severe
phenotype (Cavallo et al. 1998). Genetic and physical
interactions between TCFs and TLE family co-repres-
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sors (Cavallo et al. 1998, Roose et al. 1998) provided
further support for the transcriptional model. The
model has also been confirmed in fly cell culture using
a combination of RNAi and ChIP of TCF/Pan in the
absence and presence of Wg signalling (Fang et al.
2006).
In C. elegans, the POP-1 loss-of-function phenotypes
indicate both positive and negative roles in regulating
Wnt targets (Phillips & Kimble 2009). In some con-
texts, for example, blocking mesoderm cell fate in the
early embryo, repression of Wnt targets is the predom-
inant effect observed (Rocheleau et al. 1997, Thorpe
et al. 1997). But in other stages, for example, QL
neuroblast migration and stem cell specification in the
somatic gonad, loss of POP-1 has a similar phenotype
as loss of other Wnt/b-catenin components (Herman
2001, Lam et al. 2006). Clearly, POP-1 and TCF/Pan
can both repress and activate Wnt targets.
In vertebrates, some TCF family members are more
closely linked to either repression or activation. For
example, headless (hdl) mutants in zebrafish are loss of
function TCF3a alleles and display a lack of head
structures (Kim et al. 2000), similar to Dkk1 knockouts
in mice (Mukhopadhyay et al. 2001). While hdl
mutants could be efficiently rescued with a TCF3a
transgene, adding the VP16 domain, a potent transcrip-
tional activation domain to TCF3a, abolished rescue
activity of the transgene (Kim et al. 2000). This suggests
that most of TCF3a’s transcriptional activity is repres-
sive. Knockout of TCF3 in mice also resulted in
phenotypes associated with an increase in Wnt/b-cate-
nin signalling (Merrill et al. 2004) and siRNA inhibiton
of TCF3 in mouse ES cells largely results in increased
expression of target genes (Cole et al. 2008). In
contrast, LEF1 knockouts have phenotypes best
explained by a loss of Wnt/b-catenin signalling (van
Genderen et al. 1994, Reya et al. 2000, Kratochwil
et al. 2002).
In contrast to TCF3 and LEF1, TCF1 appears to be
more versatile. Mouse embryos lacking both TCF1 and
LEF1 have a loss of caudal somites that is reminiscent
of Wnt3a mutants (Galceran et al. 1999). TCF1 and
LEF1 also act redundantly to pattern the mesoderm in
Xenopus embryos, and this activity is linked to
transcriptional activation (Liu et al. 2005). However,
TCF1 and TCF3 have also been shown to act redun-
dantly in repressing Spemann organizer genes such as
siamois in ventral blastomeres (Houston et al. 2002,
Standley et al. 2006). Loss of the TCF1 gene in mice
demonstrated that it was a tumour suppressor in the
intestine and mammary gland (Roose et al. 1999).
The situation for TCF4 also indicates both positive
and negative roles in regulating Wnt targets. TCF4
knockouts display a loss of stem cells in the intestinal
crypts (Korinek et al. 1998), consistent with a loss of
Wnt/b-catenin signalling. Consistent with this, TCF4 is
required for activation of Spemann organizer genes in
Xenopus (Standley et al. 2006). Conversely, loss of
TCF4 can result in elevated activation of a Wnt/
b-catenin signalling in CRC cells, suggesting a possible
role for TCF4 as a tumour suppressor (Tang et al.
2008). Further support for a bi-modal role for TCF4
comes from studies of TCF3; TCF4 double knockouts in
the skin epithelia of mice (Nguyen et al. 2009). Loss of
both TCFs in the skin epithelia resulted in a dramatic
decline in epidermal survival, which was not observed
when b-catenin was removed (Nguyen et al. 2009).
Microarray profiling revealed that many genes were
repressed by TCF3 and TCF4 in a redundant manner,
which were either activated or not regulated by b-cate-
nin (Nguyen et al. 2009). These data fit a model where
the two TCFs are repressing gene expression in the
absence of Wnt/b-catenin signalling. Like TCF1, TCF4
can activate or repress Wnt targets, depending on the
context.
The loss-of-function studies summarized above sug-
gest a model where the transcriptional switch in
vertebrate WREs is mediated by two distinct TCFs.
For example, in two CRC cell lines, siRNA data fit a
model, where TCF4 represses Wnt targets in the
absence of signalling and TCF1 works with b-catenin
to activate targets (Tang et al. 2008). Given that these
results are not consistent with the phenotype of TCF1
and TCF4 knockouts in mice (Korinek et al. 1998,
Roose et al. 1999), follow-up experiments with ChIP
and reporter genes are required to confirm this model.
In the presumptive Spemann organizer, TCF3 occupies
the WRE upstream of the siamois TSS, and its binding
to chromatin is reduced by Wnt/b-catenin signalling
(Hikasa et al. 2010). It will be interesting to determine
the occupancy of TCF4 on the siamoisWRE in response
to pathway activation, since this TCF is required for
siamois regulation (Standley et al. 2006).
Functional analysis of TCF-DNA recognition in WREs
The DNA sequence motif (CCTTTGATS) that mediates
high affinity binding of TCFs in vitro (van de Wetering
et al. 1997, van Beest et al. 2000, Hallikas et al. 2006)
has been shown to be necessary and sufficient for
activation of TCF-b-catenin-dependent transcription.
This sequence motif has been found in many WREs,
that is, regulatory sequences that can activate transcrip-
tion of promoters in response to Wnt/b-catenin signal-
ling. Mutation of these motifs in these WREs abolished
activation by the pathway (He et al. 1998, Yamaguchi
et al. 1999, Barolo 2006, Chang et al. 2008a). In
addition, multiple copies of this motif placed upstream
of a minimal promoter confer Wnt/b-catenin respon-
siveness in cell culture (Korinek et al. 1997, Lum et al.
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2003, DasGupta et al. 2005) and in transgenic mice and
fish (DasGupta & Fuchs 1999, Dorsky et al. 2002,
Maretto et al. 2003, Nakaya et al. 2005). These studies,
combined with the TCF loss-of-function studies des-
cribed in the previous section have led to the view
that TCFs are the major transcriptional regulators of
Wnt/b-catenin signalling in most contexts.
Testing the functionality of TCF binding sites in
WREs has suggested that the switch model for TCF
transcriptional regulation is WRE-specific. In several
cases, mutation of the TCF binding sites clearly dem-
onstrated both a repressive and a positive role. When a
single TCF site is destroyed in the END-1 WRE, a
reduction in activation by Wnt/b-catenin signalling was
observed, but the reporter was also expressed in cells
where it was normally repressed by POP-1 (Shetty et al.
2005). Similar phenotypes were observed when TCF
sites were mutated in the siamois WRE in Xenopus
(Brannon et al. 1997, Fan et al. 1998) as well as an eve
WRE in flies (Knirr & Frasch 2001). In contrast,
mutation of TCF sites in a WRE controlling expression
of decapentapleigic (dpp) in the fly visceral mesoderm
resulted in a huge derepression of expression with no
loss in maximal activation (Yang et al. 2000). It appears
that for this WRE, Wg/Arm signalling activates expres-
sion by alleviating TCF/Pan repression. At the other
extreme, mutation of TCF sites often results in loss of
expression of the WRE reporter (Yamaguchi et al.
1999, Lee & Frasch 2000, Chang et al. 2008b). For
these WREs, there appears to be little role for TCF
repression, and regulation by the pathway occurs
through TCF-b-catenin mediated activation (see Fig. 7A
and B for further explanation).
Like many transcription factors, the TCF consensus
site is not inviolate. Many functional TCF binding sites
in WREs have one or more substitutions from the
consensus (Barolo 2006). Systematic analysis of TCF4-
DNA binding in vitro also demonstrated that single
substitutions from the CCTTTGATS consensus
reduced, but did not abolish, recognition by TCF4
(Hallikas et al. 2006). There is no strict correlation
between functional significance and adherence to the
TCF consensus site. For example, the TCF site that is










Figure 7 Variations on TCF transcriptional switches. (a & b) In organisms with a single TCF gene, the protein interacts with
co-repressors in the absence of signalling, while b-catenin binding to TCF displaces co-repressors and recruits co-activators. In
WREs from the nkd and notum genes, mutation of TCF binding sites results in a loss of activation (e) presumably due to the absence
of other transcriptional activators (Chang et al. 2008b). In other WREs such as END1 the loss of a single TCF site reduces
activation by Wnt/b-catenin signalling, but there is also significant derepression of expression in cells where the WRE is not
normally active (f, middle row), presumably due to the presence of other transcriptional activators (Shetty et al. 2005). In some
cases (e.g. the visceral mesodermal dpp WRE), mutation of the TCF sites results in full activation of expression in many cells (f,
lower row), suggesting that the primary function of b-catenin is to relieve TCF repression (Yang et al. 2000). (c) In Xenopus,
where multiple TCFs reside in the same cells, the transcriptional switch may be accomplished by HIPK2-mediated phosphorylation
of the repressive TCF3, which reduces its binding to WRE chromatin, allowing TCF1 to bind and activate transcription (Hikasa &
Sokol 2011). (d) The activity of a WRE can also be blocked by dominant negative isoforms of TCF which lack the ability to bind
b-catenin (Roose et al. 1999, Hovanes et al. 2001). See the text for additional examples of WRE regulation by TCFs. WRE, Wnt
response elements; TCF, T-cell factor; HIPK2, homeodomain interacting protein kinase 2.
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one (CCTTTCATG) or two (TCTTTCATG) changes
from the consensus, with the first site having increased
affinity for TCF4 (Tuupanen et al. 2009, Wright et al.
2010). Likewise, binding sites that are highly functional
in fly WREs from the naked cuticle (nkd) locus can have
two (GCTTTGTTC) or three (GCTTTGACA) differ-
ences from the consensus (Chang et al. 2008a). In
addition to such high affinity sites in the eve and slp1
WREs, there were also more divergent sites (e.g.
ACTTCACAG) that were footprinted by TCF/Pan
in vitro and contributed to activation in transgenic fly
reporter assays (Lee & Frasch 2000, Knirr & Frasch
2001). The heterogeneity of what constitutes a TCF
binding site makes locating biologically relevant WREs
by sequence analysis alone extremely difficult.
A simple analysis of randomly selected human inter-
genic DNA helps to illustrate how common predicted
TCF binding sites are in the genome (Table 1). Perfect
or near perfect sites (CCTTTGAWS) are rare (1 every
approx. 22 kb). But if one allows a modest level
of degeneracy, for example, SCTTTGAWS or CTTT-
GWWS, the frequency increases to 1/10 300 or 1/2500
respectively (Table 1). These sequences are well within
the range of known functional TCF sites (see preceding
paragraph and Chang et al. 2008a, Knirr & Frasch
2001, Lee & Frasch 2000). When the consensus is
loosened to the level of the polymorphic TCF site found
in the upstream c-myc WRE (GTTTGWWS; Pomerantz
et al. 2009, Tuupanen et al. 2009, Wright et al. 2010),
the frequency in random DNA is 1 in 645 bp (Table 1).
This analysis suggests that there are millions of
potential TCF binding sites in the human genome, and
the challenge for researchers is to determine how TCF
can identify functional sites among the sea of irrelevant
ones.
Bipartite binding of some TCFs through C-clamp-Helper
site interaction
Are TCF sites the only sequence information in WREs
that facilitate TCF binding? A distinct sequence motif
with a consensus of GCCGCCR (R = A/G) has been
shown to be critical for the activation of six WREs in fly
cells (Chang et al. 2008b). Unlike classic TCF sites,
multiple copies of this element (termed the Helper site)
are not sufficient for activation of a promoter/reporter
cassette. However, these elements greatly enhance the
ability of HMG domain binding sites to respond to
pathway activation (Chang et al. 2008b). While the
orientation and spacing of the Helper sites are not fixed
in relation to HMG sites, they are predominantly within
6 bp of each other. It appears that the presence of a
Helper site nearby provides additional context to the
TCF site to facilitate TCF/Pan activation of WREs
(Chang et al. 2008b).
How do Helper sites facilitate TCF-mediated activa-
tion of WREs? The breakthrough came from the
identification of an additional DNA-binding domain
found in some isoforms of vertebrate TCFs, for exam-
ple, TCF-1E and TCF-4E (Atcha et al. 2007). This
domain, coined the C-clamp, contains four highly
conserved Cysteine residues (Fig. 2). The presence of a
C-clamp downstream of the HMG domain of TCF1
enabled the protein to recognize sequences containing
the classic HMG binding site and an additional
sequence of RCCG (Atcha et al. 2007). WREs from
the LEF1 and cdx1 genes are only activated by TCFs
containing a C-clamp (Atcha et al. 2003, 2007, Hecht
& Stemmler 2003). These WREs contain RCCG motifs
in close proximity to HMG binding sites (Atcha et al.
2007). The RCCG motif from vertebrates is similar to
the first four nucleotides in the Helper site (GCCG). In
flies, the major isoform of TCF/Pan contains a C-clamp,
and this domain is required for activation of the WREs
containing Helper sites (Chang et al. 2008b). Further-
more, recombinant TCF/Pan had a dramatic increase in
affinity for HMG sites if a Helper site was present, and
this enhanced binding was C-clamp dependent (Chang
et al. 2008b). These results suggest a model where TCF/
Pan, TCF1E and TCF4E recognize DNA through a
bipartite mechanism involving HMG domain-HMG-
site and C-clamp-Helper site interactions.
In contrast to vertebrates, where only some of TCF1
and TCF4 isoforms contain a C-clamp, almost all
invertebrate genomes examined contain only one TCF
gene with a C-clamp. The fly TCF/pan locus is subject to
alternative splicing but the RNA-seq profiling indicates
that the two most abundant isoforms expressed
Table 1 The frequency of TCF sites depends on how one
defines a TCF site. An open source algorithm called Target
Explorer (Sosinsky et al. 2003) was used to create a
weighted matrix of high to lower quality TCF sites. This
matrix was used to search several stretches of human intergenic
DNA totalling 134 kb for potential TCF sites. While TCF
sites matching the high affinity consensus site (CCTTTGAWS)
are relatively rare, allowing increasing degrees of degeneracy
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throughout development (van de Wetering et al. 1997),
possess both a HMG and a C-clamp domain (see
modencode website: http://modencode.oicr.on.ca/fgb2/
gbrowse/fly/?name=4:87956..131430). While such de-
tailed analysis of TCF isoforms in other invertebrates
has not yet been performed, it appears that the ancestral
TCF gene contained both domains, and that after
amplification during the vertebrate lineage, the C-clamp
was lost (LEF1 and TCF3) or partially retained through
alternative splicing (TCF1 and TCF4) (Fig. 8). This
model makes the prediction that Helper sites will play
an important part in specifying invertebrate WREs, as
has been found in Drosophila (Chang et al. 2008b),
while additional mechanisms exist for target location of
vertebrate TCFs lacking a C-clamp. It should be pointed
out that despite the high degree of similarity among
C-clamps, some of the invertebrate domains have non-
conservative changes at some positions. For example,
the M. leidyi C-clamp has an arginine in place of the
third cysteine (Fig. 2). Direct analysis of these C-clamps
will be required to determine whether they enhance
TCF binding, as is the case for TCF/Pan, TCF1E and
TCF4E.
Genome-wide analysis of TCF binding and
targets
In an attempt to define the Wnt/b-catenin transcrip-
tome, microarray based screens have been performed in
a variety of cell types. The number of genes whose
expression is altered in the cells varies from hundreds to
thousands (van de Wetering et al. 2002, Jackson et al.
2005, Klapholz-Brown et al. 2007, Van der Flier et al.
2007). A list of these microarray studies can be found
on the Wnt homepage curated by the Nusse Lab at
http://www.stanford.edu/group/nusselab/cgi-bin/wnt/
and also at the Stanford Microarray Database website:
http://genome-www5.stanford.edu/. One simple mes-
sage from these data sets is the limited amount of
overlap between Wnt targets in different cell types. It
has been estimated that as few as 5% of targets are
identified in all studies (Vlad et al. 2008). While
variations in experimental protocols and signal detec-
tion may contribute to this low number, most of the
cell-specific differences likely reflect the existence of
discrete transcriptional programs. In one study, micro-
array analysis of PC12 and NIH3T3 cells identified 129
and 355 genes with alteration of expression in response
to Wnt3a treatment respectively (Railo et al. 2009).
Only two genes were commonly activated in both cell
lines, one of which was axin2, often considered a
universally induced feedback antagonist of Wnt/b-cate-
nin signalling (Jho et al. 2002).
While some classes of Wnt targets such as Wnt
pathway components, proliferative genes or anti-apop-
totic genes are found in multiple studies (Longo et al.
2002, Chen et al. 2007, Klapholz-Brown et al. 2007,
Van der Flier et al. 2007, Railo et al. 2009), other
classes may be more restricted in their expression
domains. For instance, angiogenic (Masckauchan et al.
Figure 8 Phylogenetic tree showing the evolution of the TCF family. The genome sequence of Monosiga brevicollis (choanofla-
gellate) reveals no TCF family member, while that of Amphimedon queenslandica (porifera), Mnemiopsis leidyi (ctenophore),
Nematostella vectensis (cnidarian), Caenorhabditis elegans (nematode), Drosophilia melanogaster (insect) and Strongylocentrotus
purpuratus (echinoderm) have a single TCF gene encoding a protein with HMG domain, basic tail and a C-clamp. Schistosoma
mansoni (Platyhelminthes) has three TCF genes; two with a C-clamp and one without. Mammals and amphibians have four TCF
genes, two of which have C-clamp containing isoforms. These patterns suggest that the last common ancestor of all metazoans
contained a single TCF gene with a C-clamp. In the two lineages where the TCF family increased in number, the C-clamp became
dispensible in some family members. TCF, t-cell factor; HMG, high mobility group.
 2011 The Authors
Acta Physiologica  2011 Scandinavian Physiological Society, doi: 10.1111/j.1748-1716.2011.02293.x 89
Acta Physiol 2012, 204, 74–109 H C Archbold et al. Æ Wnt/b-catenin transcriptional regulation
2005) or osteoblastic and adipogenic targets (Jackson
et al. 2005) are most likely Wnt responsive only in
permissive tissue specific contexts.
One limitation of microarrays is that they do not
distinguish between direct and indirect targets. ChIP-
based genomic surveys offer the potential to identify
regions of the genome that are enriched for a particular
TCF or b-catenin. How many of these bound regions
actually correspond to a functional WRE? For example,
in one study of TCF4 binding sites in LS174T cells, a
CRC cell line, over 6 800 high quality binding peaks
were identified using a ChIP-microarray approach
(Hatzis et al. 2008). More than 70% of the identified
peaks were over 10 kb from the nearest TSS, highlight-
ing the tremendous amount of genomic real estate that
must be examined when searching for WREs. In many
cases, several TCF4-bound regions were found near a
single gene, such as the 11 peaks surrounding the Axin2
gene. Four of these regions had WRE activity in a
reporter assay, while 10 out of 22 other TCF4 bound
regions from other locations tested positive in this assay
(Hatzis et al. 2008). It remains to be seen whether the
regions that tested negative in the reporter assay are
simply non-functional binding sites for TCF4 or are
WREs that are not active in a simple reporter assay. The
relatively small degree of overlap (12.5–20.5% depend-
ing on how the comparison is made) between whether a
TCF4-bound region was found within 100 kb of a TSS
from a gene upregulated in adenomas suggests that
many of these Wnt targets may be indirectly regulated
(Hatzis et al. 2008).
Another study using ChIP followed by high through-
put sequencing (ChIP-seq) identified over 20 000 TCF4
bound regions in the human CRC cell line HCT116
(Blahnik et al. 2010). Over 6000 of these motifs map to
putative enhancer regions with 10–100 kb of a TSS,
while over 9000 mapped within 2 kb of a TSS. Using
the same cell line, over 2100 regions enriched for
b-catenin binding were also reported (Bottomly et al.
2010). In this study, only 47% of the peaks contained at
least one consensus TCF motif in the vicinity of the
peak. The remaining peaks may represent TCF-inde-
pendent b-catenin targets, peaks containing TCF bind-
ing motifs which diverge from the consensus, or false
positives.
The above studies indicate that TCF4 can bind to
regions far removed from the TSS of target genes. This
suggests that the most common way of determining
whether a developmental gene is directly regulated by
Wnt/b-catenin signalling, that is, scanning the region
immediately upstream of the candidate gene’s TSS for
conserved TCF binding sites, followed by site-directed
mutagenesis, may miss many WREs. While continued
genome-wide surveys of TCF-bound chromatin in
interesting developmental contexts is desirable, an
alternative is to use computational approaches to detect
WREs within entire genomes. For example, an algo-
rithm called the enhancer element locator utilized
binding site affinity matrixes and motif clustering
conservation between two or more species to identify
potential WREs (Hallikas et al. 2006). Several putative
elements were tested in a transgenic mouse assay and
found to be expressed in patterns that were consistent
with positive regulation by Wnt/b-catenin signalling,
though this was not directly confirmed by site-directed
mutation of the conserved TCF sites (Hallikas et al.
2006). While this method is likely to identify some
WREs, the challenge of sorting through the entire
genome requires stringent screening parameters which
likely miss many biologically relevant elements. While
one of the benefits of this algorithm is the reliance on
conservation of motif clusters rather that strict sequence
conservation, in some instances, enhancer elements in
divergent species have been shown to retain functional
conservation while losing motif clustering or locational
conservation (Kalay & Wittkopp 2010), and thus may
elude this type of analysis.
Given the likelihood that many targets of the Wnt/b-
catenin pathway are cell specific, it seems that a
combination of transcriptome analysis, physical local-
ization assays (e.g. ChIP-seq) and further refinement of
computational approaches will be needed to efficiently
identify WREs in all the interesting contexts where the
pathway plays important roles. The existence of WREs
acting over great distances makes this undertaking even
more challenging. These efforts should be aided by the
realization that many Wnt targets are controlled by
TCFs in combination with other transcription factors,
often in direct contact with each other. Some of the
literature on this topic is covered in the following
section.
TCF isoforms: a complicated situation gets more so
The existence of alternative splicing and promoter
selection in vertebrate TCF genes results in a highly
complex and varied inventory of TCF isoforms. For
example, the mouse TCF4 locus contains 17 exons, and
more than a dozen TCF4 isoforms resulting from
alternative splicing have been identified (Weise et al.
2010). Four isoforms (E isoforms) contained a C-clamp,
though the protein sequence differed at 3 positions
depending on whether exon 14 or 15 was used. Three
isoforms contained a truncated C-clamp (after the third
cysteine – see Fig. 2) and three others contained new
protein sequence after position 20 of the motif (Weise
et al. 2010). These six isoforms were collectively
referred to as S isoforms, while isoforms completely
lacking the C-clamp were labelled M isoforms (Fig. 9).
Representatives from each group were compared in
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several assays and significant differences were found.
For example a TCF4E isoform could bind to and
regulate a cdx1WRE to a far greater extent than TCF4S
or TCF4M isoforms (Weise et al. 2010). The biological
role of the TCF4S isoforms merits further study but
there is data suggesting that TCF4E isoforms are
preferentially required for increased growth and prolif-
eration in some CRC cell lines (Atcha et al. 2007) and
the presence of TCF4E isoforms is correlated with
increased disease progression in renal cell carcinoma
(Shiina et al. 2003).
Another class of TCF isoforms lacks the b-catenin
binding domain normally found at the N-terminus
(Fig. 9). These isoforms are predicted to block Wnt/
b-catenin signalling, since experimentally derived TCFs
lacking this domain act as potent dominant negatives
(Behrens et al. 1996, Molenaar 1996, van de Wetering
et al. 1997, Kratochwil et al. 2002). For example, high
expression of truncated TCF1 (dnTCF1) isoforms have
been proposed to explain the tumour suppressor effect
of TCF1 in mice (Roose et al. 1999). In human
intestinal epithelial cells, LEF1 can be expressed from
two distinct promoters. Transcription from the second
promoter produces a LEF1 lacking the b-catenin bind-
ing domain (Hovanes et al. 2001). In human CRC, this
truncated LEF1 is suppressed, which is predicted to
contribute to higher levels of Wnt/b-catenin signalling
(Hovanes et al. 2001, Yokoyama et al. 2010). In
T-helper cells, dnTCF1 is thought to regulate cell
polarization via IL4 signalling. TCF1E activates
GATA3 expression, which then suppresses dnTCF1
transcription in an IL4 dependent manner. This positive
feedback loop promotes T helper cell polarization
(Maier et al. 2011).
Other TCF isoforms influence the ability of the
proteins to act in repression or activation. In Xenopus,
TCF4A contains two motifs in the central portion of the
protein (LVPQ and SXXSS) that are missing in TCF4C
(Fig. 9). TCF4A can rescue embryos depleted of TCF3,
suggesting that it can act as a repressor, while TCF4C
can rescue embryos depleted of TCF1 or LEF1,
suggesting a role in transcriptional activation (Liu et al.
2005). In CRC, expression of TCF4E isoforms clacking
a binding site for CtBP (a transcriptional co-repressor)
has been correlated with increased malignancy (Cuil-
liere-Dartigues et al. 2006). Furthermore, these iso-
forms have decreased repressive activity in cell culture
reporter assays (Cuilliere-Dartigues et al. 2006, Tang
et al. 2008).
Given the complexities of understanding even a single
TCF isoform, comprehending how the entire TCF
isoform repertoire is orchestrated to influence Wnt/b-
Figure 9 Diversity of TCF/LEFs. Invertebrates contain a single TCF member containing the b-catenin binding (green), HMG (red),
basic tail (turquoise), and C-clamp (blue) domains. Pictured here is the most abundant isoform in Drosophila (Pan A) and the
C. elegans POP-1. In vertebrates, alternate promoter usage and alternative splicing result in a myriad of TCF isoforms with
diverse functional properties. Alternate usage of downstream promoters can result in isoforms which lack the b-catenin binding
domain, and function as natural dominant negatives, such as dnTCF1 and dnLEF1 (Roose et al. 1999, Hovanes et al. 2001).
Alternate exon usage (orange) occurs in all family members except TCF3, and the LVPQ/SXXSS motif (purple) which is invariant
in TCF3 confers repressive activity on TCF4 isoforms which contain it (as in TCF4A) (Liu et al. 2005). Inclusion of the C-clamp
motif is seen in E-tail containing isoforms TCF1E and TCF4E. M isoforms lack the C-clamp, while S isoforms contain truncated
C-clamp domains (Weise et al. 2010). Some TCF3 and TCF4 isoforms also contain CtBP binding sites. TCF, T-cell factor; LEF,
lymphoid enhancer-binding factor; HMG, high mobility group.
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catenin signalling is a long-term objective for the field.
For further information on TCF isoforms, see the
following review (Arce et al. 2006).
Post-translational modifications of TCFs
Post-translational modifications of TCFs are known to
influence their subcellular localization, stability and
their ability to bind to DNA and cofactors. These
modifications can have a stimulatory or inhibitory
effect, depending on the context. For example, the
SUMO E3 ligase PIASy has been shown to facilitate
sumoylation of LEF1, resulting in sequestration of the
protein into nuclear bodies, where it cannot activate
Wnt targets (Sachdev et al. 2001). Conversely, PIASy
sumoylates TCF4, which increases its affinity for
b-catenin, promoting target gene activation (Yamamoto
et al. 2003b). The physiological role for PIASy in the
Wnt/b-catenin pathway is not clear, given that disrup-
tion of this gene in mice resulted in no morphological
defects and only mild effects on some Wnt targets (Roth
et al. 2004).
TCFs have also been shown to be acetylated by the
invertebrate homologs of CBP and p300. These histone
acetyltransferases are normally associated with histone
acetylation and gene activation (Ogryzko et al. 1996).
Indeed, CBP/p300 is known to be recruited to WREs
through binding to b-catenin/Arm and is required for
activation of Wnt targets (Mosimann et al. 2009).
Paradoxically, partial loss of fly CBP gene activity
elevated Wg/Arm signalling (Waltzer & Bienz 1998).
This was shown to be the result of CBP acetylation of
TCF/Pan on K25, a conserved lysine in the b-catenin/
Arm binding domain. This modification weakens bind-
ing of TCF/Pan to Arm (Waltzer & Bienz 1998). An
inhibitory role for CBP/p300 has also been reported in
mammalian cells, though the exact mechanism is not
clear (Li et al. 2007). In C. elegans, POP-1 can be
acetylated by human p300 at K185 just N-terminal of
the HMG domain (Gay et al. 2003). Acetylation at this
site also occurs in worms, and was required for nuclear
localization and biological activity of POP-1 (Gay et al.
2003). This region of POP1 is not well conserved in
other TCFs, so it is not clear whether this mechanism
occurs in other organisms.
Phosphorylation has also been linked to POP-1
nuclear localization. In Wnt receiving cells, a complex
of the MAP kinase LIT-1 (NLK) and WRM-1 (a worm
b-catenin) binds to POP-1 and phosphorylates it
(Rocheleau et al. 1999). This results in nuclear export
of POP-1, which is mediated by PAR-5, a 14-3-3
protein (Lo et al. 2004). This export lowers the level of
nuclear POP-1, facilitating the switch of POP-1 from a
repressor to a b-catenin (SYS-1 or BAR-1) bound
transcriptional activator (Phillips & Kimble 2009).
Interestingly, a Wnt and CaMKII-dependent efflux of
dnTCF1 has also been reported in human CRC cells
(Najdi et al. 2009).
Is the NLK-mediated phosphorylation and nuclear
export found in C. elegans operating in other organ-
isms? In Xenopus, NLK phosphorylation of TCF4 and
LEF1 promotes ubiquitylation and degradation (Ya-
mada et al. 2006). In Drosophila, overexpression of
Nemo, the fly homolog of NLK, inhibits Wg/Arm
signalling and reduction of nemo activates the pathway
(Zeng & Verheyen 2004). Whether this occurs through
nuclear efflux or degradation of TCF/Pan is not yet
known.
Several other kinases have been shown to influence
TCF activity through direct phosphorylation. CKII can
promote Wnt target gene activation by phosphorylating
LEF1, which reduces its affinity for TLE co-repressors
(Wang & Jones 2006, Sun & Weis 2011). The Traf2-
and Nck-interacting kinase (TNIK) is required for
activation of TCF4-b-catenin in mammalian cells and
can form a complex with TCF4 and b-catenin (Shitash-
ige et al. 2008, Mahmoudi et al. 2009). High levels of
TNIK have also been shown to be required for maximal
growth of CRC cell lines with elevated Wnt/b-catenin
signalling (Shitashige et al. 2010). The positive rela-
tionship between the pathway and TNIK is conserved in
Xenopus, where primary axis formation and activation
of Spemann organizer genes are dependent on TNIK
and its kinase activity (Satow et al. 2010). This study
demonstrated a b-catenin-dependent recruitment of
TNIK to the siamois and other organizer WREs,
consistent with a direct role in Wnt target gene
activation (Satow et al. 2010).
At least one other TCF phosphorylation event occurs
at Xenopus Wnt targets in early embryogenesis. In
Xenopus embryos, TCF3 is phosphorylated in response
to Wnt/b-catenin signalling (Hikasa et al. 2010). Home-
odomain interacting protein kinase 2 (HIPK2) is a
major mediator of this Wnt-dependent phosphorylation
and requires b-catenin for this activity. Reduction of
HIPK2 reduces TCF3 phosphorylation and inhibits
induction of the Spemann organizer (Hikasa et al.
2010). Importantly, expression of a TCF3 variant that
cannot be modified by HIPK2 also blocks activation of
Wnt targets. Interestingly, HIPK2-dependent phosphor-
ylation of TCF3 by Wnt/b-catenin signalling results in a
reduction of TCF3 on siamois WRE chromatin (Hikasa
et al. 2010). These data support a model where b-cate-
nin promotes HIPK2 modification of TCF3, which
results in removal from the WRE, alleviating the
repressive influence of TCF3. HIPK2 also phosphory-
lates TCFs in human cells (Hikasa & Sokol 2011), but
the functional consequence of this modification awaits
further study. In flies, HIPK2 promotes Wg signalling
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through stabilization of Arm (Lee et al. 2009), though
modification of TCF/Pan has not been excluded.
One interesting speculation is that HIPK2 and TNIK
act in concert to activate Wnt targets in the Xenopus
embryo. b-catenin allows HIPK2 to phosphorylate
TCF3, removing it from the WRE (Hikasa et al. 2010).
At the same time, b-catenin recruits TNIK to TCF4,
which somehow allows the TCF4-b-catenin complex to
activate transcription (Satow et al. 2010). In this way,
b-catenin could affect a swap of the TCFs that mediate
repression and activation respectively. Recently, it has
been shown for Vent2, a Wnt target in ventral Xenopus
blastomeres, that pathway activation results in a
replacement of TCF3 by TCF1 on the Vent2 regulatory
region (Hikasa & Sokol 2011). Since TCF3 represses
and TCF1 activates Vent2 expression (Hikasa & Sokol
2011), this study provides the first direct support for a
‘TCF switch’ model where Wnt/b-catenin signalling
promotes a physical change of distinct TCFs (Fig. 7C).
Whether other kinases such as TNIK are involved in this
switch remains to be examined.
Combinatorial interactions of TCFs and other
transcription factors
Given the flexibility of what constitutes a HMG binding
site, it is likely that this interaction is not sufficient for
TCFs to distinguish WREs from non-functional binding
sites that occur throughout the genome. Indeed, this
appears to be the case in Drosophila, where bipartite
binding to WREs occurs through HMG domain-HMG
site and C-clamp-Helper site interactions (Chang et al.
2008b). While the conservation of the C-clamp among
invertebrates (Figs 2 and 8) suggests that this strategy
may be prevalent in these organisms, what about the
situation in vertebrates, where most vertebrate TCF
isoforms do not possess a C-clamp? In this section,
several transcription factors are discussed that interact
with TCFs and/or b-catenin and appear to act cooper-
atively with TCFs to bind to regulatory elements.
One family of transcription factors that interact with
TCFs on cis-regulatory elements are the Smads, which
mediate many aspects of TGF-b signalling (Moustakas
& Heldin 2009). The Wnt/b-catenin and TGF-b path-
ways cross-talk at several levels (Eivers et al. 2009,
Itasaki & Hoppler 2010) and this review will limit the
discussion to reports where both pathways appear to
assemble Smad-TCF-b-catenin complexes on cis-acting
regulatory elements. This was first shown for the
regulatory region of the twin gene in Xenopus embryos
(Nishita et al. 2000) and mammalian cells (Labbe et al.
2000). In both contexts, both Smad and HMG binding
sites were required for maximal activation of reporter
constructs by Wnt/b-catenin and TGF-b signalling. The
HMG domain of LEF1 can directly interact with Smad
3 or Smad 4 (Labbe et al. 2000, Nishita et al. 2000).
These results suggest a model where a combination of
protein-DNA interactions and protein-protein interac-
tions can promote the formation of a Smad-TCF-b-





Figure 10 Three different mechanisms that contribute to TCF
target selection in the nucleus. (a) Bipartite binding of TCF/Pan
with HMG domain–HMG site and C-clamp–Helper site
interactions at a binding site in the intronic WRE from nkd
(Chang et al. 2008b). This strategy increases the TCF recog-
nition site to approx. 16 basepairs. (b) Combinatorial binding
between LEF1 and a Smad heterodimer on the twin WRE in
Xenopus (Labbe et al. 2000, Nishita et al. 2000). The adjacent
location of the Smad and TCF binding site again increases the
amount of basepairs required for binding. Smads and b-catenin
are also thought to cooperate in recruiting p300/CBP to TGFb
regulated WREs (Lei et al. 2004). (c) In the case of the c-jun
and c-myc regulatory regions, the TCF and AP-1 sites are not
near each other (Nateri et al. 2005, Yochum et al. 2008),
suggesting a model where DNA looping is stabilized by inter-
actions between c-Jun and TCF. TCF, T-cell factor; HMG,
high mobility group; WRE, Wnt response elements; LEF,
lymphoid enhancer-binding factor.
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Since these initial reports, other genes have been
identified that are co-regulated by TCFs and Smads.
Most of these studies are in the context of cell culture,
with regulatory elements from the Msx2 (Hussein et al.
2003), c-myc (Hu & Rosenblum 2005), gastrin (Lei
et al. 2004, Chakladar et al. 2005), Sm22a (Shafer &
Towler 2009), TMEPA1 (Nakano et al. 2010) and
several osteogenic genes (Rodriguez-Carballo et al.
2011). But the existence of functional Smad and TCF
binding sites in close proximity to each other has also
been found in Emx2 elements active in the developing
CNS of the mouse (Theil et al. 2002, Suda et al. 2010).
While these studies mostly relied on reporter constructs,
there is some ChIP data to suggest that Wnt/b-catenin
signalling can increase Smad recruitment to regulatory
chromatin (Hussein et al. 2003, Shafer & Towler
2009). Conversely, TGF-b signalling can recruit LEF-1
or TCF4 to chromatin as well (Hussein et al. 2003,
Nakano et al. 2010). The presence of both Smad and
b-catenin on the chromatin has been proposed to
increase binding for the histone acetyltransferases
CBP/p300, leading to increased histone acetylation
and transcription (Lei et al. 2004, Rodriguez-Carballo
et al. 2011) (Fig. 10B).
Another transcription factor linked with TCF-b-cate-
nin transcriptional activation is c-Jun, a basic leucine
zipper domain protein that can bind DNA specifically
as a homodimer or as a heterodimer with c-fos
(constituting AP-1) (Shaulian & Karin 2002). In CRC
cells, c-Jun, TCF4 and b-catenin cooperated in activat-
ing the c-Jun expression (Nateri et al. 2005). Phosphor-
ylated c-Jun was found to associate with TCF4 and both
transcription factors occupy the c-Jun regulatory region
(Nateri et al. 2005). These data complement genetic
interaction studies in the mouse intestine to support a
model, where Wnt/b-catenin signalling acts with c-Jun
in a positive feedback loop to promote carcinogenesis
(Nateri et al. 2005, Sancho et al. 2009). In contrast to
most of the elements co-regulated by TCF and Smad,
the distance of the functional TCF and AP-1 site
suggests the existence of a DNA loop stabilized by
protein-protein and protein-DNA interactions
(Fig. 10C).
While, the Wnt/b-catenin-c-Jun autoregulatory loop
may be crucial for intestinal cancer in mice and CRC in
humans, additional evidence suggests that many Wnt
transcriptional targets in CRC cells are co-regulated by
TCF4 and c-Jun. The c-myc WRE located downstream
of the c-myc gene (Fig. 6) contains a functional AP-1
site that is required for synergistic activation between
the Wnt/b-catenin pathway and serum-derived mitogens
(Yochum et al. 2008). A genome-wide survey of chro-
matin sites with b-catenin enrichment revealed that
40% of the b-catenin bound regions contain both TCF
and AP-1 binding sites (Bottomly et al. 2010). More
than a dozen sites were bound by TCF4, b-catenin and
c-Jun. As previously shown for c-myc, the activation of
several Wnt targets were enhanced by serum in CRC
cells arrested in G0/G1 (Bottomly et al. 2010). The
connection between Wnt/b-catenin signalling and cell
cycle progression has also been noted further upstream
in the pathway (Davidson & Niehrs 2010).
The Wnt/b-catenin pathway-c-Jun connection has
also been observed outside the context of intestinal
cells and CRC. Regulatory elements controlling either
the matrilysin gene in kidney or the versican gene in
melanoma require both TCF and AP-1 sites (Rivat et al.
2003, Domenzain-Reyna et al. 2009). In addition,
interactions between TCF4 and c-Jun (Gan et al.
2008) or b-catenin and the AP-1 complex (Toualbi
et al. 2007) can regulate Wnt targets independent of
AP-1 binding sites, though whether this type of regu-
lation occurs under physiological conditions is not clear.
The Smad and c-Jun/AP-1 studies described above are
examples where distinct signalling pathways and Wnt/
b-catenin signalling converge on regulatory elements to
activate transcription. Such combinatorial control of
Wnt targets can also occur through interactions with
transcription factors not directly controlled by cell–cell
signalling. One candidate for such factors is the Cdx
family of homeodomain proteins. As outlined in a
previous section, cdx1 and cdx4 are known to be direct
transcriptional targets of the Wnt/b-catenin pathway
(Lickert et al. 2000, Ikeya & Takada 2001, Pilon et al.
2006). In addition, there is some developmental genetic
data suggesting that the TCF-b-catenin complex may
functionally interact with Cdx proteins (Young et al.
2009). Indeed, Cdx1 autoregulation has been shown to
require a Cdx1-LEF1-b-catenin complex, through direct
interactions between the homeodomain and HMG
domains (Beland et al. 2004). More recently, a gen-
ome-wide survey of Cdx2 binding in intestinal cell lines
revealed a significant overlap between Cdx2 and TCF4
chromatin bound regions (Verzi et al. 2010). TCF4
binding to chromatin was found to be partially depen-
dent on Cdx2 at several locations (Verzi et al. 2010).
Interestingly, nested TCF-Cdx binding sites have been
shown to be required for an intronic raldh2 enhancer
that is active in the dorsal spinal cord of the chick
(Castillo et al. 2010).
There are other examples of TCFs interacting with
other transcription factors to regulate gene expression.
LEF1 and microphthalmia-associated transcription fac-
tor are thought to physically interact to regulate gene
expression in melanocyte differentiation (Yasumoto
et al. 2002). Likewise, LEF1 and the homeodomain
protein Pitx2 may interact in the developing dental
epithelium and other tissues (Amen et al. 2007). The
short list of transcription factors that interact with TCFs
discussed here is likely only the tip of the iceberg. The
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genome-wide studies of TCF4 binding patterns have
found an enrichment for many other transcription
factor binding sites besides AP-1, including NF1,
PPARc, HNF4, Elk-1, GATA3, c-Ets-1, Bach-1 and
FoxD-1 (Hatzis et al. 2008, Blahnik et al. 2010).
TCF-protein interactions may be the normative mech-
anism to locate WREs in the information rich nucleus,
though the binding partner is likely to be different for
different targets. It should also be noted that while the
mechanisms described above have been assumed to
operate for TCFs lacking C-clamps, they may also
function to facilitate target gene location of C-clamp
containing TCFs. It seems likely that multiple mecha-
nisms acting in concert are required for TCFs to locate
WREs in the genome.
TCF-independent recruitment of b-catenin to
Wnt targets
TCFs are clearly the best characterized transcription
factors that mediate the regulation of gene expression
via Wnt/b-catenin signalling. In addition to TCFs, there
are several other DNA-binding proteins that have been
shown to bind to b-catenin and effect transcriptional
responses. Many nuclear receptors, including the
oestrogen and androgen receptors bind b-catenin and
co-regulate targets of these hormones, as reviewed
elsewhere (Mulholland et al. 2005, Beildeck et al.
2010). In this section, we discuss other transcription
factors that serve as recruiters for nuclear b-catenin and
how they may contribute to the enormous diversity of
transcriptional outputs that are generated by the Wnt/
b-catenin pathway.
To conclude that a transcription factor is sufficient to
recruit b-catenin to a regulatory element, the factor
must bind and co-regulate targets with b-catenin. This is
the case for Sox17, which regulates endodermal genes
during vertebrate gastrulation. b-catenin augments
Sox17¢s ability to activate target genes and the two
proteins physically interact (Sinner et al. 2004). How-
ever, a role for TCFs in this process was not ruled out
and in CRC cells, Sox17 has also been shown to interact
with TCFs and promote their degradation (Sinner et al.
2007). In another case, the homeodomain protein Prop1
and b-catenin are both required for Pit1 expression in
the developing mouse pituitary gland (Olson et al.
2006). These proteins directly interact and are co-local-
ized on Pit1 regulatory chromatin. LEF1 is not required
for Pit1 expression, but other TCF family members were
not examined (Olson et al. 2006). PitX2 can also bind
to b-catenin and bring it to the cyclin D2 promoter in
mouse myoblast cells (Kioussi et al. 2002). A synthetic
enhancer containing multimerized PitX2 sites is acti-
vated in a b-catenin-dependent manner, suggesting that
PitX2 is sufficient for recruiting b-catenin to DNA
(Kioussi et al. 2002). It should be pointed out that
PitX2 can also bind LEF1, suggesting that it sometimes
works with TCFs to regulate Wnt targets (Vadlamudi
et al. 2005, Amen et al. 2007).
One approach to rule out a role for TCFs in the
activation of target genes by b-catenin is the use of
dominant negative constructs of TCF (dnTCF) that
cannot bind b-catenin. When expressed at sufficient
levels, such constructs should prevent the binding of
endogenous TCFs to regulatory elements (Behrens et al.
1996, Molenaar 1996, van de Wetering et al. 1997,
Kratochwil et al. 2002). In cultured myoblasts, b-cate-
nin is required for the bHLH protein MyoD to activate
muscle specific genes (Kim et al. 2008). The presence of
high levels of b-catenin enhanced MyoD binding to
myogenic elements, presumably through direct binding.
This regulation was not affected by expression of
dnTCF (Kim et al. 2008). dnTCF also did not block
the ability of b-catenin to augment transcriptional
activation of hypoxia inducible factor 1a (HIF1a) (Kaidi
et al. 2007).
In CRC cells with high endogenous levels of b-cate-
nin, hypoxia (which dramatically increases HIF1a
levels) results in a shift of b-catenin away from the
classic Wnt target c-myc towards HIF1a targets (Kaidi
et al. 2007). It should be noted that this effect is cell
specific, since in several stem cells, hypoxia activates
Wnt/b-catenin signalling by HIF1a-dependent induction
of LEF1 and TCF1 transcription and b-catenin protein
levels (Mazumdar et al. 2010). In these cells, sufficient
b-catenin is thought to allow both types of transcription
factors to activate target genes (Mazumdar et al. 2010).
Another example where a stress-induced factor can
divert b-catenin away from TCFs is the FOXO family
of Forkhead domain transcription factors. FOXO
proteins can directly bind b-catenin and use it to
activate gene expression in C. elegans and mammalian
cells (Essers et al. 2005). Induction of FOXO protein
levels during oxidative stress reduces TCF-dependent
gene expression, due to competition for limiting levels
of b-catenin (Almeida et al. 2007, Hoogeboom et al.
2008).
How important are non-TCFs in mediating Wnt/
b-catenin signalling during normal development? In
cnidarians, the only functional data thus far on TCFs
suggests that in Hydra, TCF is absolutely required for
Wnt-dependent head regeneration (Duffy et al. 2010).
In Drosophila, Tcf/pan mutants clearly are qualitatively
similar to wg mutants (Brunner et al. 1997, van de
Wetering et al. 1997, Schweizer et al. 2003), but it is
not clear that it is required for all Wg signalling. In
vertebrates, the role of TCFs is much more difficult to
assess, given the likely redundancy between the four
TCFs. While the available data suggests that vertebrates
TCFs play a major role in mediating Wnt/b-catenin
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signalling, the sum of all other transcription factors
recruiting b-catenin to Wnt target genes may ultimately
be much more significant than currently appreciated.
Direct transcriptional repression by b-catenin
This review has focused exclusively on the ability of
b-catenin to activate transcription, which is reasonable
considering the large pile of evidence for such a role. But
it is worth noting that Wnt/b-catenin signalling leads to
down-regulation of gene expression about as often as
activating genes (van de Wetering et al. 2002, Jung &
Kim 2005, Naishiro et al. 2005, Klapholz-Brown et al.
2007). Because of the pathway’s obvious role in
activation, it is usually assumed that these genes are
indirectly repressed by Wnt/b-catenin signalling, that is,
the pathway activates a repressor that then inhibits
another genes expression. While this no doubt occurs,
there are a growing number of cases where b-catenin is
thought to directly mediate repression through TCF
family members. This is distinct from the well-known
repressive role of TCFs in the absence of signalling that
has been previously discussed.
What are the experimental criteria for determining
that a target is directly repressed by Wnt/b-catenin
signalling? A straightforward approach is to monitor
target gene expression when the pathway is activated in
cells treated with protein synthesis inhibitors. While,
this is straightforward for many pathways, for example,
TGFb (Kang et al. 2003), it is problematic for Wnt/
b-catenin signalling, given the requirement for new
synthesis of b-catenin once its degradation is blocked
(see Fig. 1). There are hormone-inducible versions of
b-catenin, created by fusing portions of a nuclear
receptor to b-catenin, and these have been used to
determine activation of targets in the presence of
protein synthesis inhibitors (Li et al. 2009, Elkouby
et al. 2010). But these reagents can be tricky to utilize
for identifying direct targets of repression (Blauwkamp
et al. 2008).
In lieu of this approach, researchers have used a
combination of site-directed mutagenesis of TCF bind-
ing sites in repressed cis-regulatory elements to provide
support for direct regulation. In flies, such studies have
shown that WREs from the stripe and dpp genes contain
TCF sites that are absolutely required for repression
(Piepenburg et al. 2000, Theisen et al. 2007). In cell
culture, a luciferase reporter has been used in a similar
way to demonstrate that Wnt/b-catenin signalling
directly represses E-cadherin in keratinocytes (Jamora
et al. 2003), and p16INK4a in melanoma (Delmas et al.
2007). In these cases, ChIP was also employed to
demonstrate that TCF and b-catenin were physically
present on the repressed WREs (Jamora et al. 2003,
Delmas et al. 2007).
What is known about the mechanism of these
examples of TCF-b-catenin repression? For the stripe
WRE, the functional TCF binding site overlaps with a
binding site for Cubitus Interruptis (Ci), which is crucial
for activation of stripe in embryos (Piepenburg et al.
2000). This suggests that TCF/Pan-Arm may displace
the Ci activator. In the case of dpp, Brinker binds to the
WRE and somehow acts with TCF/Pan-Arm to mediate
repression in the leg imaginal disc (Theisen et al. 2007).
In keratinocytes, LEF1-b-catenin works additively with
the Snail repressor to inhibit E-cadherin transcription
(Jamora et al. 2003). It is not clear in these cases or that
of pINK16a where the specificity lies that allows TCF-
b-catenin to repress, rather than activate, gene expres-
sion.
Another example of direct repression by the pathway
occurs in cultured hemocytic cells in Drosophila, where
Wg/Arm signalling represses expression of Ugt36Bc, an
enzyme deposited in the extracellular matrix (Blauwk-
amp et al. 2008). TCF/Pan is enriched in the same
region upstream of the Ugt36Bc TSS that contains a
WRE that is repressed by the pathway. This WRE was
localized to a 178 bp region that contained no classic
TCF binding sites. However, footprinting revealed the
existence of three TCF sites, which share a consensus of
AGAWAW. These sites are functional, mediating acti-
vation of the WRE in the absence of signalling and Arm-
dependent repression (Blauwkamp et al. 2008). Thus,
Ugt36Bc is regulated by a ‘reverse transcriptional
switch’ compared with the classic switch depicted in
Fig. 1.
The existence of novel TCF binding sites in the Ugt
reporter suggested that the nature of the binding site
contained the specificity for the transcriptional output.
Support for this came from an experiment where the
novel sites were converted to classic ones. Strikingly,
this altered WRE was now activated in response to Wg/
Arm signalling (Blauwkamp et al. 2008). The possibility
of allosteric regulation of TCFs by DNA is supported by
structural analysis of the LEF1 HMG domain alone and
when complexed with a high affinity binding site. When
the HMG is not bound by DNA, it is partially
unstructured, particularly helix 1. Upon DNA binding,
the HMG domain is converted to a well-folded, highly
ordered state (Love et al. 2004). It would not be
surprising if different DNA-binding sites could influence
the conformation of TCF, which could then influence
the recruitment of co-activators or co-repressors by
b-catenin/Arm.
Another clue to the mechanism of TCF/Arm direct
repression was found through mutagenesis of the Arm
gene. Deletion or mutation of portions of Arm known
to be involved in transcriptional activation created a
variant called DisArmed. Consistent with the altera-
tions, DisArmed could not regulate several WREs that
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are activated by the pathway (Blauwkamp et al. 2008).
However it could still efficiently repress Ugt36Bc
expression and the Ugt reporter. In addition, DisArmed
could repress several other downregulated Wg targets in
cultured cells and fly hemocytes, suggesting that they
also are directly repressed by TCF/Pan-Arm (Blauwk-
amp et al. 2008).
As is the case with activated Wnt targets, there are
also reports of non-TCF proteins utilizing b-catenin to
repress gene expression. The best studied is the home-
odomain protein Prop1, discussed earlier as a transcrip-
tion factor that binds b-catenin to activate transcription
(Olson et al. 2006). Like TCFs, it can also do the
opposite, recruiting b-catenin to a regulatory element
controlling another transcription factor called Hesx1
(Olson et al. 2006). This repression requires reptin, a
transcriptional co-repressor (Olson et al. 2006). The
antimetastasis gene KAI1 is also repressed by a complex
containing b-catenin and Reptin, but the DNA-binding
transcription factor is not known (Kim et al. 2005).
Interestingly, Reptin is known to bind to b-catenin/Arm
in a region that is not altered in the DisArmed protein
(Bauer et al. 2000), though it is not known whether fly
Reptin is involved in Ugt36Bc repression by Wg/Arm
signalling.
As with other variations from the classic regulatory
mechanism outlined in Fig. 1, it is not yet clear how
often direct repression by b-catenin occurs, either
through TCFs or other transcription factors. Is it a
rarity that plays only a small role in transcriptional
regulation by the Wnt/b-catenin pathway? Or has the
focus on transcriptional activation and classic TCF
binding sites obscured a currently underappreciated
aspect of Wnt gene regulation? Clearly more research in
this area is required to find out.
Conclusions
The first detailed characterizations of Wg/Arm signal-
ling already revealed what is now a common assump-
tion, that this single pathway has a remarkable number
of roles during fly development (Baker 1988, Peifer
et al. 1991). The appreciation of Wnt/b-catenin signal-
ling diversity has only grown in the past twenty years,
and this review has only covered a small fraction of the
established roles of the pathway in metazoan develop-
ment. How is this diversity achieved? In vertebrates,
differences among the TCF family members and the
large number of other transcription factors that recruit
b-catenin to WREs is likely part of the answer. But in
flies, it thus far appears that a single TCF mediates
most, if not all of the Wg/Arm pathway’s effects
(Brunner et al. 1997, van de Wetering et al. 1997,
Schweizer et al. 2003). Combinatorial inputs from
other signalling pathways certainly provide an answer
for why some WREs are activated in a cell-specific
manner, for example, eve in cardiac mesoderm (Halfon
et al. 2000, Lee & Frasch 2000, Knirr & Frasch 2001,
Han et al. 2002). Other mechanisms, for example, cell-
specific chromatin accessibility, are thought to occur
(Wohrle et al. 2007), but remain relatively unexplored.
Despite the challenge of understanding the complex-
ities ofWg target gene regulation, our current knowledge
is detailed enough so that it can be exploited to further
understand how this pathway controls development. The
realization of an ancient posterior Wnt signalling gradi-
ent throughout metazoans (Petersen & Reddien 2009,
Niehrs 2010), provides one example. For cnidarians, we
think it likely that the potentially important targets (e.g.
Brachyury) will be bound by TCFs by a similar bipartite
mechanism as has been shown to operate in Drosophila
(Chang et al. 2008b), given the presence of highly
conserved HMG and C-clamp domains in cnidarians
(Figs 2 and 8). Using information from other systems
may allow the dissection of the genetic networks in great
detail, complementing the careful analysis of regulatory
factors that are expressed temporally downstream of
Wnts, exemplified by the study of the amphibian NC (Li
et al. 2009, Elkouby et al. 2010) (Fig. 4). Perhaps in the
near future, a combination of genome-wide surveys,
WRE identification through bioinformatics and
informed examination of candidate target genes can
identify important targets relatively quickly in many
developmental systems.
This dynamic can be observed in the study of the
Wnt/b-catenin pathway in CRC. The identification of a
WRE more than 335 kb removed from the c-myc TSS
could have only been achieved with a combination of
genomic approaches and a recognition of what consti-
tutes a TCF binding site (Pomerantz et al. 2009,
Tuupanen et al. 2009, Sotelo et al. 2010, Wright et al.
2010) (Fig. 6). Optimization of these approaches should
facilitate the identification of relevant targets for the
many other pathologies that Wnt/b-catenin signalling
has now been linked to.
Despite intense effort over the past 15 years, there is
much to learn about how TCFs (and other transcription
factors) transform elevated levels of nuclear b-catenin
into the appropriate transcriptional responses in a cell,
tissue and temporally specific manner. The vast size of
metazoan genomes and the great distances over which
WREs can operate make this task even more daunting.
Given the importance of this pathway in normal devel-
opment and physiology as well as numerous pathologies,
it’s clear that further investigation is worth the effort.
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